Hubbry Logo
DiseaseDiseaseMain
Open search
Disease
Community hub
Disease
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Disease
Disease
Disease
View on Wikipedia
from Wikipedia

"The Sick Girl", by Michael Ancher, 1882, National Gallery of Denmark

A disease is a particular abnormal condition that adversely affects the structure or function of all or part of an organism and is not immediately due to any external injury.[1] Diseases are often known to be medical conditions that are associated with specific signs and symptoms. A disease may be caused by external factors such as pathogens or by internal dysfunctions. For example, internal dysfunctions of the immune system can produce a variety of different diseases, including various forms of immunodeficiency, hypersensitivity, allergies, and autoimmune disorders.

In humans, disease is often used more broadly to refer to any condition that causes pain, dysfunction, distress, social problems, or death to the person affected, or similar problems for those in contact with the person. In this broader sense, it sometimes includes injuries, disabilities, disorders, syndromes, infections, isolated symptoms, deviant behaviors, and atypical variations of structure and function, while in other contexts and for other purposes these may be considered distinguishable categories. Diseases can affect people not only physically but also mentally, as contracting and living with a disease can alter the affected person's perspective on life.

Death due to disease is called death by natural causes. There are four main types of disease: infectious diseases, deficiency diseases, hereditary diseases (including both genetic and non-genetic hereditary diseases), and physiological diseases. Diseases can also be classified in other ways, such as communicable versus non-communicable diseases. The deadliest diseases in humans are coronary artery disease (blood flow obstruction), followed by cerebrovascular disease and lower respiratory infections.[2] In developed countries, the diseases that cause the most sickness overall are neuropsychiatric conditions, such as depression and anxiety.

Pathology, the study of disease, includes etiology, or the study of cause.

Terminology

[edit]

Concepts

[edit]

In many cases, terms such as disease, disorder, morbidity, sickness and illness are used interchangeably; however, there are situations when specific terms are considered preferable.[3]

Disease
The term disease broadly refers to any condition that impairs the normal functioning of the body. For this reason, diseases are associated with the dysfunction of the body's normal homeostatic processes.[4] Commonly, the term is used to refer specifically to infectious diseases, which are clinically evident diseases that result from the presence of pathogenic microbial agents, including viruses, bacteria, fungi, protozoa, multicellular organisms, and aberrant proteins known as prions. An infection or colonization that does not and will not produce clinically evident impairment of normal functioning, such as the presence of the normal bacteria and yeasts in the gut, or of a passenger virus, is not considered a disease. By contrast, an infection that is asymptomatic during its incubation period, but expected to produce symptoms later, is usually considered a disease. Non-infectious diseases are all other diseases, including most forms of cancer, heart disease, and genetic disease.
Acquired disease
An acquired disease is one that began at some point during one's lifetime, as opposed to disease that was already present at birth, which is congenital disease. Acquired sounds like it could mean "caught via contagion", but it simply means acquired sometime after birth. It also sounds like it could imply secondary disease, but acquired disease can be primary disease.
Acute disease
An acute disease is one of a short-term nature (acute); the term sometimes also connotes a fulminant nature
Chronic condition or chronic disease
A chronic disease is one that persists over time, often for at least six months, but may also include illnesses that are expected to last for the entirety of one's natural life.
Congenital disorder or congenital disease
A congenital disorder is one that is present at birth. It is often a genetic disease or disorder and can be inherited. It can also be the result of a vertically transmitted infection from the mother, such as HIV/AIDS.
Genetic disease
A genetic disorder or disease is caused by one or more genetic mutations. It is often inherited, but some mutations are random and de novo.
Hereditary or inherited disease
A hereditary disease is a type of genetic disease caused by genetic mutations that are hereditary (and can run in families)
Iatrogenic disease
An iatrogenic disease or condition is one that is caused by medical intervention, whether as a side effect of a treatment or as an inadvertent outcome.
Idiopathic disease
An idiopathic disease has an unknown cause or source. As medical science has advanced, many diseases with entirely unknown causes have had some aspects of their sources explained and therefore shed their idiopathic status. For example, when germs were discovered, it became known that they were a cause of infection, but particular germs and diseases had not been linked. In another example, it is known that autoimmunity is the cause of some forms of diabetes mellitus type 1, even though the particular molecular pathways by which it works are not yet understood. It is also common to know certain factors are associated with certain diseases; however, association does not necessarily imply causality. For example, a third factor might be causing both the disease, and the associated phenomenon.
Incurable disease
A disease that cannot be cured. Incurable diseases are not necessarily terminal diseases, and sometimes a disease's symptoms can be treated sufficiently for the disease to have little or no impact on quality of life.
Primary disease
A primary disease is a disease that is due to a root cause of illness, as opposed to secondary disease, which is a sequela, or complication that is caused by the primary disease. For example, a common cold is a primary disease, where rhinitis is a possible secondary disease, or sequela. A doctor must determine what primary disease, a cold or bacterial infection, is causing a patient's secondary rhinitis when deciding whether or not to prescribe antibiotics.
Secondary disease
A secondary disease is a disease that is a sequela or complication of a prior, causal disease, which is referred to as the primary disease or simply the underlying cause (root cause). For example, a bacterial infection can be primary, wherein a healthy person is exposed to bacteria and becomes infected, or it can be secondary to a primary cause, that predisposes the body to infection. For example, a primary viral infection that weakens the immune system could lead to a secondary bacterial infection. Similarly, a primary burn that creates an open wound could provide an entry point for bacteria, and lead to a secondary bacterial infection.
Terminal disease
A terminal disease is one that is expected to have the inevitable result of death. Previously, AIDS was a terminal disease; it is now incurable, but can be managed indefinitely using medications.
Illness
The terms illness and sickness are both generally used as synonyms for disease; however, the term illness is occasionally used to refer specifically to the patient's personal, subjective experience of their disease.[5][6][7][8] In this model, it is possible for a person to have a disease without being ill (to have an objectively definable, but asymptomatic, medical condition, such as a subclinical infection, or to have a clinically apparent physical impairment but not feel sick or distressed by it), and to be ill without being diseased (such as when an objectively healthy person perceives a normal experience as a medical condition, or medicalizes a non-disease situation in their life – for example, a person who feels unwell as a result of embarrassment, and who interprets those feelings as sickness rather than normal emotions). Symptoms of illness are often not directly the result of infection, but a collection of evolved responses – sickness behavior by the body – that helps clear infection and promote recovery. Such aspects of illness can include lethargy, depression, loss of appetite, sleepiness, hyperalgesia, and inability to concentrate.[9][10][11]
Disorder
A disorder is a functional abnormality or disturbance that may or may not show specific signs and symptoms. Medical disorders can be categorized into mental disorders, physical disorders, genetic disorders, emotional and behavioral disorders, and functional disorders.[12] The term disorder is often considered more value-neutral and less stigmatizing than the terms disease or illness, and therefore is preferred terminology in some circumstances.[13] In mental health, the term mental disorder is used as a way of acknowledging the complex interaction of biological, social, and psychological factors in psychiatric conditions; however, the term disorder is also used in many other areas of medicine, primarily to identify physical disorders that are not caused by infectious organisms, such as metabolic disorders.
Medical condition or health condition
A medical condition or health condition is a broad concept that includes all diseases, lesions, disorders, or nonpathologic condition that normally receives medical treatment, such as pregnancy or childbirth. While the term medical condition generally includes mental illnesses, in some contexts the term is used specifically to denote any illness, injury, or disease except for mental illnesses. The Diagnostic and Statistical Manual of Mental Disorders (DSM), the widely used psychiatric manual that defines all mental disorders, uses the term general medical condition to refer to all diseases, illnesses, and injuries except for mental disorders.[14] This usage is also commonly seen in the psychiatric literature. Some health insurance policies also define a medical condition as any illness, injury, or disease except for psychiatric illnesses.[15]
As it is more value-neutral than terms like disease, the term medical condition is sometimes preferred by people with health issues that they do not consider deleterious. However, by emphasizing the medical nature of the condition, this term is sometimes rejected, such as by proponents of the autism rights movement.
The term medical condition is also a synonym for medical state, in which case it describes an individual patient's current state from a medical standpoint. This usage appears in statements that describe a patient as being in critical condition, for example.
Morbidity
Morbidity (from Latin morbidus 'sick, unhealthy') is a diseased state, disability, or poor health due to any cause.[16] The term may refer to the existence of any form of disease, or to the degree that the health condition affects the patient. Among severely ill patients, the level of morbidity is often measured by ICU scoring systems. Comorbidity, or co-existing disease, is the simultaneous presence of two or more medical conditions, such as schizophrenia and substance abuse.
In epidemiology and actuarial science, the term morbidity (also morbidity rate or morbidity frequency) can refer to either the incidence rate, the prevalence of a disease or medical condition, or the percentage of people who experience a given condition within a given timeframe (e.g., 20% of people will get influenza in a year).[17] This measure of sickness is contrasted with the mortality rate of a condition, which is the proportion of people dying during a given time interval. Morbidity rates are used in actuarial professions, such as health insurance, life insurance, and long-term care insurance, to determine the premiums charged to customers. Morbidity rates help insurers predict the likelihood that an insured will contract or develop any number of specified diseases.
Pathosis or pathology
Pathosis (plural pathoses) is synonymous with disease. The word pathology also has this sense, in which it is commonly used by physicians in the medical literature, although some editors prefer to reserve pathology to its other senses. Sometimes a slight connotative shade causes preference for pathology or pathosis implying "some [as yet poorly analyzed] pathophysiologic process" rather than disease implying "a specific disease entity as defined by diagnostic criteria being already met". This is hard to quantify denotatively, but it explains why cognitive synonymy is not invariable.
Syndrome
A syndrome is the association of several signs and symptoms, or other characteristics that often occur together, regardless of whether the cause is known. Some syndromes such as Down syndrome are known to have only one cause (an extra chromosome at birth). Others such as Parkinsonian syndrome are known to have multiple possible causes. Acute coronary syndrome, for example, is not a single disease itself but is rather the manifestation of any of several diseases including myocardial infarction secondary to coronary artery disease. In yet other syndromes, however, the cause is unknown. A familiar syndrome name often remains in use even after an underlying cause has been found or when there are a number of different possible primary causes. Examples of the first-mentioned type are that Turner syndrome and DiGeorge syndrome are still often called by the "syndrome" name despite that they can also be viewed as disease entities and not solely as sets of signs and symptoms.
Predisease
Predisease is a subclinical or prodromal vanguard of a disease. Prediabetes and prehypertension are common examples. The nosology or epistemology of predisease is contentious, though, because there is seldom a bright line differentiating a legitimate concern for subclinical or premonitory status and the conflict of interest–driven over-medicalization (e.g., by pharmaceutical manufacturers) or de-medicalization (e.g., by medical and disability insurers). Identifying legitimate predisease can result in useful preventive measures, such as motivating the person to get a healthy amount of physical exercise,[18] but labeling a healthy person with an unfounded notion of predisease can result in overtreatment, such as taking drugs that only help people with severe disease or paying for treatments with a poor benefit–cost ratio.
One review proposed three criteria for predisease:
  • a high risk for progression to disease making one "far more likely to develop" it than others are- for example, a pre-cancer will almost certainly turn into cancer over time
  • actionability for risk reduction – for example, removal of the precancerous tissue prevents it from turning into a potentially deadly cancer
  • benefit that outweighs the harm of any interventions taken – removing the precancerous tissue prevents cancer, and thus prevents a potential death from cancer.[19]

Types by body system

[edit]
Mental
Mental illness is a broad, generic label for a category of illnesses that may include affective or emotional instability, behavioral dysregulation, cognitive dysfunction or impairment. Specific illnesses known as mental illnesses include major depression, generalized anxiety disorders, schizophrenia, and attention deficit hyperactivity disorder, to name a few. Mental illness can be of biological (e.g., anatomical, chemical, or genetic) or psychological (e.g., trauma or conflict) origin. It can impair the affected person's ability to work or study and can harm interpersonal relationship.
Organic
An organic disease is one caused by a physical or physiological change to some tissue or organ of the body. The term sometimes excludes infections. It is commonly used in contrast with mental disorders. It includes emotional and behavioral disorders if they are due to changes to the physical structures or functioning of the body (such as after a stroke or a traumatic brain injury — organic brain disease is a dated term for such cases) but not if they are due to psychosocial issues.

Stages

[edit]

In an infectious disease, the incubation period is the time between infection and the appearance of symptoms. The latency period is the time between infection and the ability of the disease to spread to another person, which may precede, follow, or be simultaneous with the appearance of symptoms. Some viruses also exhibit a dormant phase, called viral latency, in which the virus hides in the body in an inactive state. For example, varicella zoster virus causes chickenpox in the acute phase; after recovery from chickenpox, the virus may remain dormant in nerve cells for many years, and later cause herpes zoster (shingles).

Acute disease
An acute disease is a short-lived disease, like the common cold.
Chronic disease
A chronic disease is one that lasts for a long time, usually at least six months. During that time, it may be constantly present, or it may go into remission and periodically relapse. A chronic disease may be stable (does not get any worse) or it may be progressive (gets worse over time). Some chronic diseases can be permanently cured. Most chronic diseases can be beneficially treated, even if they cannot be permanently cured.
Clinical disease
One that has clinical consequences; in other words, the stage of the disease that produces the characteristic signs and symptoms of that disease.[20] AIDS is the clinical disease stage of HIV infection.
Cure
A cure is the end of a medical condition or a treatment that is very likely to end it, while remission refers to the disappearance, possibly temporarily, of symptoms. Complete remission is the best possible outcome for incurable diseases.
Flare-up
"Flareup" redirects here. For the Transformers character, see Flareup (Transformers).
See also: Exacerbation
A flare-up can refer to either the recurrence of symptoms or an onset of more severe symptoms.[21]
Progressive disease
Progressive disease is a disease whose typical natural course is the worsening of the disease until death, serious debility, or organ failure occurs. Slowly progressive diseases are also chronic diseases; many are also degenerative diseases. The opposite of progressive disease is stable disease or static disease: a medical condition that exists, but does not get better or worse.
Refractory disease
A refractory disease is a disease that resists treatment, especially an individual case that resists treatment more than is normal for the specific disease in question.
Subclinical disease
Also called silent disease, silent stage, or asymptomatic disease. This is a stage in some diseases before the symptoms are first noted.[22]
Terminal phase
If a person will die soon from a disease, regardless of whether that disease typically causes death, then the stage between the earlier disease process and active dying is the terminal phase.
Recovery
See also: Convalescence and Recuperation
Recovery can refer to the repairing of physical processes (tissues, organs etc.) and the resumption of healthy functioning after damage causing processes have been cured.

Extent

[edit]
skin rash on the leg
This rash only affects one part of the body, so it is a localized disease.
Localized disease
A localized disease is one that affects only one part of the body, such as athlete's foot or an eye infection.
Disseminated disease
A disseminated disease has spread to other parts; with cancer, this is usually called metastatic disease.
Systemic disease
A systemic disease is a disease that affects the entire body, such as influenza or high blood pressure.

Classification

[edit]
Main articles: Nosology and Medical classification

Diseases may be classified by cause, pathogenesis (mechanism by which the disease is caused), or by symptoms. Alternatively, diseases may be classified according to the organ system involved, though this is often complicated since many diseases affect more than one organ.

A chief difficulty in nosology is that diseases often cannot be defined and classified clearly, especially when cause or pathogenesis are unknown. Thus diagnostic terms often only reflect a symptom or set of symptoms (syndrome).

Classical classification of human disease derives from the observational correlation between pathological analysis and clinical syndromes. Today it is preferred to classify them by their cause if it is known.[23]

The most known and used classification of diseases is the World Health Organization's ICD. This is periodically updated. Currently, the last publication is the ICD-11.

Causes

[edit]
See also: Cause (medicine) and Transmission (medicine)

Diseases can be caused by any number of factors and may be acquired or congenital. Microorganisms, genetics, the environment or a combination of these can contribute to a diseased state.[24]

Only some diseases such as influenza are contagious and commonly believed infectious. The microorganisms that cause these diseases are known as pathogens and include varieties of bacteria, viruses, protozoa, and fungi. Infectious diseases can be transmitted, e.g. by hand-to-mouth contact with infectious material on surfaces, by bites of insects or other carriers of the disease, and from contaminated water or food (often via fecal contamination), etc.[25] Also, there are sexually transmitted diseases. In some cases, microorganisms that are not readily spread from person to person play a role, while other diseases can be prevented or ameliorated with appropriate nutrition or other lifestyle changes.

Some diseases, such as most (but not all) forms of cancer, heart disease, and mental disorders, are non-infectious diseases. Many non-infectious diseases have a partly or completely genetic basis (see genetic disorder) and may thus be transmitted from one generation to another.

Social determinants of health are the social conditions in which people live that determine their health. Illnesses are generally related to social, economic, political, and environmental circumstances.[26] Social determinants of health have been recognized by several health organizations such as the Public Health Agency of Canada and the World Health Organization to greatly influence collective and personal well-being. The World Health Organization's Social Determinants Council also recognizes Social determinants of health in poverty.

When the cause of a disease is poorly understood, societies tend to mythologize the disease or use it as a metaphor or symbol of whatever that culture considers evil. For example, until the bacterial cause of tuberculosis was discovered in 1882, experts variously ascribed the disease to heredity, a sedentary lifestyle, depressed mood, and overindulgence in sex, rich food, or alcohol, all of which were social ills at the time.[27]

When a disease is caused by a pathogenic organism (e.g., when malaria is caused by Plasmodium), one should not confuse the pathogen (the cause of the disease) with disease itself. For example, West Nile virus (the pathogen) causes West Nile fever (the disease). The misuse of basic definitions in epidemiology is frequent in scientific publications.[28]

Types of causes

[edit]
A child rides a bicycle. An adult and a child walk a dog along a path in a green park..
Regular physical activity, such as riding a bicycle or walking, reduces the risk of lifestyle diseases.
Airborne
An airborne disease is any disease that is caused by pathogens and transmitted through the air.[29]
Foodborne
Foodborne illness or food poisoning is any illness resulting from the consumption of food contaminated with pathogenic bacteria, toxins, viruses, prions or parasites.[30]
Infectious
Infectious diseases, also known as transmissible diseases or communicable diseases, comprise clinically evident illness (i.e., characteristic medical signs or symptoms of disease) resulting from the infection, presence and growth of pathogenic biological agents in an individual host organism.[31] Included in this category are contagious diseases – an infection, such as influenza or the common cold, that commonly spreads from one person to another – and communicable diseases – a disease that can spread from one person to another, but does not necessarily spread through everyday contact.
Lifestyle
A lifestyle disease is any disease that appears to increase in frequency as countries become more industrialized and people live longer, especially if the risk factors include behavioral choices like a sedentary lifestyle or a diet high in unhealthful foods such as refined carbohydrates, trans fats, or alcoholic beverages.[32]
Non-communicable
A non-communicable disease is a medical condition or disease that is non-transmissible.[33] Non-communicable diseases cannot be spread directly from one person to another. Heart disease and cancer are examples of non-communicable diseases in humans.[34]

Prevention

[edit]
Main article: Preventive medicine

Many diseases and disorders can be prevented through a variety of means. These include sanitation, proper nutrition, adequate exercise, vaccinations and other self-care and public health measures, such as obligatory face mask mandates[citation needed].

Treatments

[edit]
Main article: Therapy

Medical therapies or treatments are efforts to cure or improve a disease or other health problems. In the medical field, therapy is synonymous with the word treatment. Among psychologists, the term may refer specifically to psychotherapy or "talk therapy". Common treatments include medications, surgery, medical devices, and self-care. Treatments may be provided by an organized health care system, or informally, by the patient or family members.

Preventive healthcare is a way to avoid an injury, sickness, or disease in the first place. A treatment or cure is applied after a medical problem has already started. A treatment attempts to improve or remove a problem, but treatments may not produce permanent cures, especially in chronic diseases. Cures are a subset of treatments that reverse diseases completely or end medical problems permanently. Many diseases that cannot be completely cured are still treatable. Pain management (also called pain medicine) is that branch of medicine employing an interdisciplinary approach to the relief of pain and improvement in the quality of life of those living with pain.[35]

Treatment for medical emergencies must be provided promptly, often through an emergency department or, in less critical situations, through an urgent care facility.

Epidemiology

[edit]
Main article: Epidemiology

Epidemiology is the study of the factors that cause or encourage diseases. Some diseases are more common in certain geographic areas, among people with certain genetic or socioeconomic characteristics, or at different times of the year.

Epidemiology is considered a cornerstone methodology of public health research and is highly regarded in evidence-based medicine for identifying risk factors for diseases. In the study of communicable and non-communicable diseases, the work of epidemiologists ranges from outbreak investigation to study design, data collection, and analysis including the development of statistical models to test hypotheses and the documentation of results for submission to peer-reviewed journals. Epidemiologists also study the interaction of diseases in a population, a condition known as a syndemic. Epidemiologists rely on a number of other scientific disciplines such as biology (to better understand disease processes), biostatistics (the current raw information available), Geographic Information Science (to store data and map disease patterns) and social science disciplines (to better understand proximate and distal risk factors). Epidemiology can help identify causes as well as guide prevention efforts.

In studying diseases, epidemiology faces the challenge of defining them. Especially for poorly understood diseases, different groups might use significantly different definitions. Without an agreed-on definition, different researchers may report different numbers of cases and characteristics of the disease.[36]

Some morbidity databases are compiled with data supplied by states and territories health authorities, at national levels[37][38] or larger scale (such as European Hospital Morbidity Database (HMDB))[39] which may contain hospital discharge data by detailed diagnosis, age and sex. The European HMDB data was submitted by European countries to the World Health Organization Regional Office for Europe.

Burdens of disease

[edit]

Disease burden is the impact of a health problem in an area measured by financial cost, mortality, morbidity, or other indicators.

There are several measures used to quantify the burden imposed by diseases on people. The years of potential life lost (YPLL) is a simple estimate of the number of years that a person's life was shortened due to a disease. For example, if a person dies at the age of 65 from a disease, and would probably have lived until age 80 without that disease, then that disease has caused a loss of 15 years of potential life. YPLL measurements do not account for how disabled a person is before dying, so the measurement treats a person who dies suddenly and a person who died at the same age after decades of illness as equivalent. In 2004, the World Health Organization calculated that 932 million years of potential life were lost to premature death.[40]

The quality-adjusted life year (QALY) and disability-adjusted life year (DALY) metrics are similar but take into account whether the person was healthy after diagnosis. In addition to the number of years lost due to premature death, these measurements add part of the years lost to being sick. Unlike YPLL, these measurements show the burden imposed on people who are very sick, but who live a normal lifespan. A disease that has high morbidity, but low mortality, has a high DALY and a low YPLL. In 2004, the World Health Organization calculated that 1.5 billion disability-adjusted life years were lost to disease and injury.[40] In the developed world, heart disease and stroke cause the most loss of life, but neuropsychiatric conditions like major depressive disorder cause the most years lost to being sick.

Disease category Percent of all YPLLs lost, worldwide[40] Percent of all DALYs lost, worldwide[40] Percent of all YPLLs lost, Europe[40] Percent of all DALYs lost, Europe[40] Percent of all YPLLs lost, US and Canada[40] Percent of all DALYs lost, US and Canada[40]
Infectious and parasitic diseases, especially lower respiratory tract infections, diarrhea, AIDS, tuberculosis, and malaria 37% 26% 9% 6% 5% 3%
Neuropsychiatric conditions, e.g. depression 2% 13% 3% 19% 5% 28%
Injuries, especially motor vehicle accidents 14% 12% 18% 13% 18% 10%
Cardiovascular diseases, principally heart attacks and stroke 14% 10% 35% 23% 26% 14%
Premature birth and other perinatal deaths 11% 8% 4% 2% 3% 2%
Cancer 8% 5% 19% 11% 25% 13%

Society and culture

[edit]
Obesity was a status symbol in Renaissance culture: "The Tuscan General Alessandro del Borro", attributed to Andrea Sacchi, 1645.[41] It is now generally regarded as a disease.

How a society responds to diseases is the subject of medical sociology.

A condition may be considered a disease in some cultures or eras but not in others. For example, obesity was associated with prosperity and abundance, and this perception persists in many African regions, especially since the beginning of the HIV/AIDS.[42] Epilepsy is considered a sign of spiritual gifts among the Hmong people.[43]

Sickness confers the social legitimization of certain benefits, such as illness benefits, work avoidance, and being looked after by others. The person who is sick takes on a social role called the sick role. A person who responds to a dreaded disease, such as cancer, in a culturally acceptable fashion may be publicly and privately honored with higher social status.[44] In return for these benefits, the sick person is obligated to seek treatment and work to become well once more. As a comparison, consider pregnancy, which is not interpreted as a disease or sickness, even if the mother and baby may both benefit from medical care.

Most religions grant exceptions from religious duties to people who are sick. For example, one whose life would be endangered by fasting on Yom Kippur or during the month of Ramadan is exempted from the requirement, or even forbidden from participating.[45][46] People who are sick are also exempted from social duties. For example, ill health is the only socially acceptable reason for an American to refuse an invitation to the White House.[47]

The identification of a condition as a disease, rather than as simply a variation of human structure or function, can have significant social or economic implications. The controversial recognition of diseases such as repetitive stress injury (RSI) and post-traumatic stress disorder (PTSD) has had a number of positive and negative effects on the financial and other responsibilities of governments, corporations, and institutions towards individuals, as well as on the individuals themselves. The social implication of viewing aging as a disease could be profound, though this classification is not yet widespread.

Lepers were people who were historically shunned because they had an infectious disease, and the term "leper" still evokes social stigma. Fear of disease can still be a widespread social phenomenon, though not all diseases evoke extreme social stigma.

Social standing and economic status affect health. Diseases of poverty are diseases that are associated with poverty and low social status; diseases of affluence are diseases that are associated with high social and economic status. Which diseases are associated with which states vary according to time, place, and technology. Some diseases, such as diabetes mellitus, may be associated with both poverty (poor food choices) and affluence (long lifespans and sedentary lifestyles), through different mechanisms. The term lifestyle diseases describes diseases associated with longevity and that are more common among older people. For example, cancer is far more common in societies in which most members live until they reach the age of 80 than in societies in which most members die before they reach the age of 50.

Language of disease

[edit]

An illness narrative is a way of organizing a medical experience into a coherent story that illustrates the sick individual's personal experience.

People use metaphors to make sense of their experiences with disease. The metaphors move disease from an objective thing that exists to an affective experience. The most popular metaphors draw on military concepts: Disease is an enemy that must be feared, fought, battled, and routed. The patient or the healthcare provider is a warrior, rather than a passive victim or bystander. The agents of communicable diseases are invaders; non-communicable diseases constitute internal insurrection or civil war. Because the threat is urgent, perhaps a matter of life and death, unthinkably radical, even oppressive, measures are society's and the patient's moral duty as they courageously mobilize to struggle against destruction. The War on Cancer is an example of this metaphorical use of language.[48] This language is empowering to some patients, but leaves others feeling like they are failures.[49]

Another class of metaphors describes the experience of illness as a journey: The person travels to or from a place of disease, and changes himself, discovers new information, or increases his experience along the way. He may travel "on the road to recovery" or make changes to "get on the right track" or choose "pathways".[48][49] Some are explicitly immigration-themed: the patient has been exiled from the home territory of health to the land of the ill, changing identity and relationships in the process.[50] This language is more common among British healthcare professionals than the language of physical aggression.[49]

Some metaphors are disease-specific. Slavery is a common metaphor for addictions: The alcoholic is enslaved by drink, and the smoker is captive to nicotine. Some cancer patients treat the loss of their hair from chemotherapy as a metonymy or metaphor for all the losses caused by the disease.[48]

Some diseases are used as metaphors for social ills: "Cancer" is a common description for anything that is endemic and destructive in society, such as poverty, injustice, or racism. AIDS was seen as a divine judgment for moral decadence, and only by purging itself from the "pollution" of the "invader" could society become healthy again.[48] More recently, when AIDS seemed less threatening, this type of emotive language was applied to avian flu and type 2 diabetes mellitus.[51] Authors in the 19th century commonly used tuberculosis as a symbol and a metaphor for transcendence. People with the disease were portrayed in literature as having risen above daily life to become ephemeral objects of spiritual or artistic achievement. In the 20th century, after its cause was better understood, the same disease became the emblem of poverty, squalor, and other social problems.[50]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Disease

View on Grokipedia
from Grokipedia

A disease constitutes an abnormality in the function or structure of body organs and systems, representing a deviation from normal physiological processes that impairs an organism's . These conditions manifest through verifiable signs, symptoms, or pathological changes, often requiring intervention to mitigate distress or dysfunction. Empirically, diseases arise from causal agents including microbial pathogens, genetic , environmental toxins, or lifestyle factors that disrupt , with infectious variants transmitted via direct contact, vectors, or contaminated sources, while non-communicable forms stem from endogenous defects or chronic exposures. Classification systems, such as the (ICD), categorize ailments by , affected systems, or duration—distinguishing acute from chronic—to facilitate , treatment, and epidemiological tracking. Globally, diseases account for the majority of human mortality and morbidity, underscoring the imperative of causal identification through rigorous empirical methods over speculative attributions.

Fundamental Concepts

Definition and Core Attributes

A disease constitutes a pathological state wherein an organism's normal structural or functional integrity is disrupted, leading to impaired physiological processes that compromise , , or . This disruption manifests through verifiable deviations from species-typical norms, often evidenced by objective signs (e.g., measurable physiological changes like elevated blood glucose in ) or subjective symptoms (e.g., or ), and is causally linked to underlying etiologies such as pathogens, genetic mutations, or environmental insults. From a biomedical standpoint, diseases are not mere statistical anomalies but harmful departures from , where the body's adaptive mechanisms fail to maintain equilibrium, resulting in morbidity or increased mortality risk. Core attributes of disease include , the initiating cause or set of causes; , the mechanistic sequence by which the etiology produces cellular or tissue-level damage; morphologic changes, such as , , or neoplasia observable via or ; and functional derangements, which translate these alterations into clinical impairments like organ failure or reduced mobility. These elements form a causal chain: for instance, in , etiology involves Streptococcus pneumoniae invasion, pathogenesis entails alveolar and fluid accumulation, morphologic changes include consolidated lung tissue, and functional derangements manifest as and respiratory distress. Empirical relies on correlating these attributes with reproducible patterns across populations, prioritizing causal verification over subjective interpretations to avoid overpathologizing benign variations. Diseases inherently involve a teleological mismatch, where the affected processes no longer serve the organism's fitness goals, distinguishing them from adaptive responses or aging-related decline unless the latter crosses into dysfunction (e.g., accelerating beyond compensatory arterial remodeling). This framework underscores causal realism: not all deviations qualify as disease without demonstrated harm, as evidenced by longitudinal studies linking specific disruptions to adverse outcomes like shortened lifespan or . Disease refers to an objective pathophysiological process characterized by a specific , such as an infectious agent, genetic , or environmental , leading to detectable structural or functional abnormalities in the body, verifiable through clinical examination, laboratory tests, or . In contrast, illness denotes the subjective experience of discomfort, symptoms, or impaired reported by the individual, which may or may not correlate with an underlying disease and often incorporates dimensions like perceived severity or cultural interpretations of . This distinction underscores that diseases can exist asymptomatically, as in latent infections, while illnesses may arise without objective , such as in cases of psychogenic symptoms. A syndrome differs from a disease primarily in the absence of a unified causal mechanism or defined ; it represents a recognizable cluster of that co-occur but lack a singular identifiable origin, serving as a descriptive category until further is elucidated. For instance, involves chromosomal (a known genetic cause, blurring lines toward disease classification), whereas aggregates gastrointestinal symptoms without a consistent pathophysiological explanation. Diseases, by comparison, imply a reproducible link between cause and effect, enabling targeted interventions like antimicrobials for bacterial diseases. Disorders are typically broader and encompass functional disruptions in bodily or mental processes without necessarily requiring a precisely identified cause, often overlapping with syndromes but extending to conditions like anxiety disorders where neurochemical imbalances are implicated yet not fully causal. Unlike diseases, which denote a pathological entity with empirical biomarkers (e.g., elevated glucose in diabetes mellitus), disorders may persist as provisional labels for symptom complexes awaiting refined mechanistic understanding. Injuries represent acute disruptions from external mechanical, , or chemical forces, such as fractures or lacerations, distinguishable from diseases by their non-endogenous origin and lack of progressive cellular or systemic absent ongoing insult. Diseases involve intrinsic breakdowns, like neoplastic growth or autoimmune-mediated tissue destruction, whereas injuries demand immediate repair rather than etiological reversal. The term condition serves as an umbrella encompassing , disorders, syndromes, or any deviation from physiological norms, but lacks the specificity of by not implying a delimited causal pathway or predictable progression. This vagueness renders "condition" useful in lay or preliminary contexts but less precise for biomedical compared to , which prioritizes verifiable over mere descriptive aggregation.

Classification Frameworks

Etiological Categories

Diseases are classified etiologically according to their underlying causes, a framework that prioritizes identifying specific causal agents or mechanisms to inform pathogenesis, diagnosis, and intervention. This approach, rooted in the study of etiology as the origins of disease, distinguishes conditions based on whether the cause is microbial, genetic, environmental, or otherwise verifiable through empirical evidence such as laboratory isolation of pathogens or genetic sequencing. When the etiology is unknown, diseases are labeled idiopathic, underscoring gaps in current scientific understanding rather than assuming multifactorial complexity without evidence. Major etiological categories include infectious causes, where pathogens such as bacteria, viruses, fungi, or parasites invade host tissues, triggering immune responses and tissue damage; examples encompass from Mycobacterium tuberculosis and from orthomyxoviruses, confirmed via culture or PCR testing. Genetic etiologies involve inherited mutations or de novo alterations in DNA, leading to disorders like due to CFTR gene defects or from 21, identifiable through karyotyping or sequencing. Toxic or environmental causes arise from exposure to chemicals, radiation, or pollutants, as in from asbestos fibers or , where causal links are established by dose-response epidemiological data and findings. Hereditary and deficiency-related etiologies highlight internal disruptions, such as single-gene disorders in heredity or conditions like scurvy from vitamin C deficiency, where restoration of the missing nutrient reverses symptoms, demonstrating direct causality. Autoimmune etiologies, involving aberrant immune attacks on self-tissues, include type 1 diabetes from pancreatic beta-cell destruction, supported by autoantibody detection and histopathological evidence. Neoplastic diseases stem from uncontrolled cellular proliferation often initiated by genetic mutations, as in colorectal cancer linked to APC gene alterations, verified through tumor genomics. Degenerative etiologies, such as Alzheimer's disease involving amyloid-beta plaques and tau tangles, reflect age-related protein misfolding without a single external trigger, though amyloid hypothesis trials have yielded mixed results. Multifactorial etiologies combine elements, like from interactions of , , and , where randomized trials such as the quantify relative risks. Iatrogenic causes, unintended effects of medical interventions, include antibiotic-associated Clostridium difficile , with incidence rates rising post-broad-spectrum therapy. This classification evolves with advances in and , refining categories as new causal pathways emerge, such as viral integrations in certain cancers.

Systemic and Functional Classifications

Systemic classification organizes diseases primarily by the body system or anatomical region affected, providing a structured approach for clinical , treatment specialization, and epidemiological tracking. The World Health Organization's (ICD-11) exemplifies this through its chapter-based structure, dedicating sections to specific systems such as diseases of the (Chapter 11), (Chapter 12), and (Chapter 8). This method aggregates conditions like and under circulatory disorders, or and under respiratory issues, enabling consistent global data collection on and outcomes. Key systemic categories in the ICD-11 include:
  • Circulatory system diseases: Encompassing vascular and cardiac pathologies, such as and arrhythmias, which impair blood flow and oxygenation.
  • Respiratory system diseases: Covering obstructive and restrictive conditions, including chronic and interstitial lung diseases, often linked to airflow limitation.
  • Digestive system diseases: Involving disruptions, such as and , affecting nutrient absorption and waste elimination.
  • Musculoskeletal system diseases: Including and , which compromise mobility and structural integrity.
This classification supports resource allocation in healthcare but can oversimplify multisystemic conditions, such as , which spans and joint involvement yet is grouped under musculoskeletal or immune-related chapters. Functional classification, in contrast, evaluates diseases through their impact on physiological processes, daily activities, and social participation, rather than anatomical locus. The WHO's International of Functioning, Disability and Health (ICF), adopted in 2001, frames this by categorizing health domains into body functions (e.g., sensory, neuromusculoskeletal, and cardiovascular functions), body structures, activities (task execution like walking or communicating), and participation (life roles like or community involvement), modulated by environmental and personal factors. For example, diabetes mellitus disrupts metabolic body functions, potentially limiting activities such as self-care and restricting participation in work due to fatigue or complications like neuropathy. The ICF complements coding in the ICD by quantifying functional impairments, facilitating rehabilitation planning and assessment across etiologies. It employs a biopsychosocial perspective, recognizing that functional loss arises from interactions between disease pathology and contextual barriers, such as inaccessible environments exacerbating mobility deficits in . This approach, while not diagnostic, enhances outcome measurement; for instance, post-stroke recovery might be tracked via improvements in functions and domestic activities. Limitations include its descriptive rather than causal focus, requiring integration with etiological data for comprehensive analysis.

Duration, Severity, and Extent

Diseases are classified by duration into acute, subacute, and chronic categories based on the temporal course of symptoms and . Acute diseases manifest suddenly and resolve within a short period, typically less than 4 weeks, such as many bacterial infections or injuries that self-limit or respond rapidly to intervention. Subacute conditions bridge acute and chronic phases, lasting 4 to 8 weeks, often involving incomplete resolution or transitional , as seen in certain respiratory or musculoskeletal disorders. Chronic diseases persist beyond 12 weeks or indefinitely, imposing ongoing limitations on function or requiring continuous management, exemplified by conditions like or that alter long-term . These distinctions derive from empirical observation of recovery patterns rather than arbitrary thresholds, influencing prognostic expectations and therapeutic strategies. Severity grading quantifies the intensity of physiological disruption, organ impairment, or symptom burden, commonly stratified as mild, moderate, or severe to guide clinical decision-making. Mild severity involves minimal functional compromise without threat to vital systems, such as grade 1 changes in showing subtle alterations. Moderate severity entails noticeable but non-life-threatening effects, including partial or persistent symptoms requiring intervention, often defined by intermediate scores in disease-specific indices like the Activity Index. Severe cases feature profound impacts, such as widespread tissue damage, hemodynamic instability, or high mortality risk, graded as level 3 or 4 in standardized scales encompassing life-threatening features. Severity assessments rely on measurable criteria like values, , or validated scoring systems, varying by but prioritizing causal impacts on over subjective reports. The extent of disease delineates the spatial distribution of pathological processes, categorized as localized or systemic to reflect containment versus dissemination. Localized or focal extent confines effects to a single organ, tissue, or region, as in a contained abscess or neoplasm without metastasis, permitting targeted excision or therapy. Systemic or diffuse extent involves multi-organ involvement or widespread physiological derangement, driven by hematogenous spread, immune dysregulation, or intrinsic propagation, such as in sepsis or autoimmune disorders affecting connective tissues. These metrics, grounded in anatomical and histopathological evidence, inform epidemiological tracking and intervention scope, with systemic forms generally correlating to higher complexity and poorer outcomes due to interdependent organ failures.

Etiological Factors

Infectious Pathogens

Infectious pathogens encompass a diverse array of microorganisms and proteinaceous agents capable of invading host organisms, replicating or propagating within them, and eliciting pathological responses that impair vital functions. These agents include , viruses, fungi, , multicellular parasites such as helminths, and prions, each exploiting host cellular machinery or tissues to establish . Disease arises when pathogen load exceeds host defenses, often through mechanisms like tissue , secretion, or immune modulation, with the severity determined by the agent's —the degree to which it overcomes host barriers and induces damage. Virulence factors, such as bacterial adhesins for host cell attachment or viral proteins that evade , enable pathogens to colonize sites, multiply, and disseminate, frequently via transmission routes including respiratory droplets, contaminated water, vectors like mosquitoes, or direct contact. Bacteria, single-celled prokaryotes lacking a nucleus, account for numerous acute and chronic infections by producing exotoxins or endotoxins that lyse cells or trigger excessive ; for instance, , a gram-negative transmitted by vectors, caused the of 1346–1353, which killed an estimated 25–50 million people in , comprising 30–60% of the continent's population through septicemic and pneumonic dissemination leading to organ failure. Viruses, acellular entities consisting of genetic material encased in protein coats, require host cells for replication and often induce cytopathic effects or immune-mediated damage; severe acute respiratory syndrome coronavirus 2 (), identified in December 2019, has caused over 7 million confirmed deaths globally as of 2024 by inflaming respiratory epithelia and promoting cytokine storms, though case fatality rates vary from 0.5–3% depending on variants and host factors. Fungi, eukaryotic organisms thriving in immunocompromised hosts, typically cause opportunistic infections via spore inhalation or skin breaches, as seen in Candida species overgrowth leading to systemic with mortality rates up to 40% in intensive care settings. Protozoan parasites, single-celled eukaryotes like Plasmodium species responsible for , invade erythrocytes and hepatocytes, causing cyclic fevers and ; the disease kills approximately 600,000 people annually, predominantly in , through merozoite replication cycles that rupture cells and trigger splenic sequestration. Helminths, macroscopic worms such as , induce chronic pathology via mechanical obstruction, nutrient competition, or allergic responses, infecting over 1 billion people worldwide and contributing to in endemic regions. Prions, misfolded proteins lacking nucleic acids, propagate by inducing conformational changes in host prion proteins, leading to neurodegenerative spongiform encephalopathies; (BSE), or "mad cow disease," emerged in the UK in 1986 from feed contaminated with infected tissues, transmitting to humans as variant Creutzfeldt-Jakob disease with a near-100% fatality rate and incubation periods of 10–20 years. Host susceptibility modulates outcomes, with factors like age, , and prior immunity influencing whether exposure results in asymptomatic carriage, localized , or disseminated disease.

Genetic and Hereditary Elements

Genetic diseases result from alterations in an individual's DNA, including point mutations, insertions, deletions, or structural changes that disrupt gene function, protein production, or regulatory elements. These alterations can occur de novo during gamete formation or cell division, or be inherited from parents, leading to hereditary diseases where pathogenic variants are transmitted across generations. Mechanisms include base substitutions that alter codons, frameshift mutations causing premature stop signals, and copy number variations affecting gene dosage. Monogenic disorders arise from variants in a single gene and follow predictable Mendelian inheritance patterns, such as autosomal dominant (e.g., Huntington's disease, caused by CAG repeat expansions in the HTT gene, leading to neuronal degeneration with onset typically between ages 30-50), autosomal recessive (e.g., cystic fibrosis, due to mutations in the CFTR gene impairing chloride transport and affecting approximately 70,000 individuals worldwide), X-linked recessive (e.g., hemophilia A, from F8 gene variants disrupting clotting factor VIII), and X-linked dominant. These conditions often exhibit high penetrance, with affected individuals showing consistent phenotypes, though expressivity varies. Polygenic diseases involve interactions among multiple genetic variants, each contributing small effects, often alongside environmental factors, and do not follow simple Mendelian patterns. Examples include , where genome-wide association studies identify over 400 loci influencing risk, and , shaped by cumulative polygenic burden rather than single variants. estimates from twin studies, comparing monozygotic (sharing 100% DNA) and dizygotic (sharing ~50%) pairs, indicate genetic factors account for 40-80% of variance in such complex traits, as seen in ( ~80%) or (~60%), underscoring additive genetic influences over shared environments. Chromosomal abnormalities, involving gains or losses of entire chromosomes or large segments, represent another hereditary category, often arising from during . Trisomy 21 (), with an extra , occurs in about 1 in 800 births and causes , congenital heart defects, and increased risk due to imbalances. X (), featuring a missing or partial in females, affects 1 in 2,000-2,500 live female births, leading to , ovarian dysgenesis, and cardiovascular anomalies from of X-linked genes. These aneuploidies highlight how structural genomic errors propagate diseases independently of single nucleotide changes. Mitochondrial inheritance, a non-nuclear pattern, transmits diseases via maternally derived mtDNA mutations affecting energy production, as in (LHON), where point mutations in MT-ND1 or related genes cause vision loss in young adults with incomplete influenced by nuclear-mitochondrial interactions. Overall, while monogenic and chromosomal disorders provide clear causal links amenable to targeted diagnostics like sequencing, polygenic risks rely on polygenic risk scores derived from population genomics, revealing how modulates disease susceptibility across populations.

Environmental and Toxic Exposures

Environmental exposures encompass airborne pollutants, chemical contaminants in water and soil, and physical agents such as radiation, which can initiate or exacerbate disease through mechanisms including DNA mutagenesis, oxidative stress, and endocrine interference. Toxic exposures, often anthropogenic, demonstrate dose-dependent relationships with health outcomes, where chronic low-level contact yields cumulative effects akin to those from acute poisoning. Epidemiological studies, bolstered by toxicological data, attribute over 25% of global disease burden to such factors, with causation established in cases like asbestos-induced mesothelioma via fiber-induced inflammation and genetic alterations. Air pollution, particularly fine particulate matter (PM2.5) from combustion sources, elevates risks of respiratory infections, , and by penetrating alveoli and entering bloodstreams, triggering . In 2023, contributed to 7.9 million premature deaths worldwide, ranking as the second leading after poor diet, with 99% of the global population exposed to levels exceeding WHO guidelines. Long-term exposure correlates with reduced function and increased incidence, supported by cohort studies controlling for confounders like . Heavy metals such as lead, mercury, and bioaccumulate via contaminated water, food, and soil, causing , , and organ failure through enzyme inhibition and generation. Lead exposure in children, historically from leaded phased out by 1996 in the U.S., impairs , with blood lead levels above 5 μg/dL linked to IQ reductions of 2-4 points per 10 μg/dL increment in prospective studies. Mercury, from industrial emissions and fish consumption, induces symptoms including and sensory loss, as documented in 1956 Japanese outbreaks affecting thousands. in , affecting 140 million people globally as of 2020 estimates, causes lesions, , and cancers of the , , and , with relative risks exceeding 2 in high-exposure cohorts. Asbestos fibers, inhaled during or prior to bans in many countries (e.g., U.S. partial ban in ), lodge in pleural tissues, provoking chronic inflammation and mesothelial cell transformation into malignant , a cancer with latency periods of 20-50 years. Sufficient evidence from occupational cohorts shows multiplies risk by 5-fold in smokers, with annual U.S. diagnoses around 3,000 as of 2021 data, nearly all attributable to prior exposure. Pesticides like organochlorines and organophosphates act as endocrine disruptors, mimicking hormones and altering , with links to hormone-dependent cancers and neurodegenerative diseases. Prospective analyses associate exposure with risk increases of 41% in highly exposed applicators, per 2015 meta-analyses of agricultural workers. DDT metabolites persist in , correlating with odds ratios of 1.5-2 in women with high serum levels from longitudinal studies. Parkinson's disease incidence rises with exposure, evidenced by dose-response gradients in farming populations. Ionizing radiation from radon gas seeping into homes and ultraviolet (UV) rays from solar exposure damage DNA via direct ionization or pyrimidine dimer formation, respectively, elevating cancer risks. Radon, the second leading lung cancer cause after smoking, accounts for 21,000 U.S. deaths annually, with relative risks of 1.1 per 100 Bq/m³ increase in residential exposure from pooled miner and home studies. UV exposure drives over 90% of non-melanoma skin cancers and 65% of melanomas, with fair-skinned individuals showing incidence rates up to 100-fold higher in sunny regions per UV index data. These exposures often interact synergistically with genetic susceptibilities or co-factors like , amplifying disease beyond additive effects, as seen in asbestos-smoke synergies. Remediation via exposure reduction—e.g., lead abatement yielding 20-30% IQ gains in affected populations—underscores causal pathways, though underreporting in low-resource areas and by socioeconomic factors challenge attribution in observational data.

Lifestyle and Behavioral Influences

Lifestyle and behavioral factors represent modifiable contributors to disease risk, primarily through their impact on noncommunicable diseases (NCDs) such as , cancer, , and chronic respiratory conditions. According to the (WHO), key behavioral risks include use, unhealthy diets, physical inactivity, and harmful alcohol consumption, which drive over 70% of premature NCD deaths globally. These factors operate via causal mechanisms like , , and metabolic disruption, amplifying susceptibility to pathological processes. Tobacco smoking stands as the leading preventable cause of mortality, responsible for more than 480,000 deaths annually in the United States alone, with global figures exceeding 8 million including secondhand exposure. It elevates risks for , , and cardiovascular events through direct endothelial damage and carcinogen exposure, with cessation reducing these hazards substantially within years. Unhealthy dietary patterns and resultant independently heighten disease incidence; correlates with elevated risks of , heart disease, and certain cancers via adipose tissue-mediated and proinflammatory cytokines. Physical inactivity compounds this, affecting nearly 1.8 billion adults worldwide and ranking as the fourth leading mortality by promoting sedentary-induced . Excessive alcohol intake contributes to 178,000 annual U.S. deaths and 2.6 million globally, linking to liver , cancers, and neuropsychiatric disorders through toxicity and hepatic overload. Chronic , often behavioral in origin, associates with heightened chronic disease burdens including , , and cardiovascular , as evidenced by longitudinal studies showing disrupted sleep patterns predict metabolic dysregulation. Interventions targeting these behaviors, such as policy-driven reductions in and alcohol access, demonstrate causal reductions in attributable disease fractions.

Pathophysiological Processes

Mechanisms of Onset and Propagation

The onset of disease generally occurs through a primary pathophysiological that disrupts normal cellular or tissue , often initiated by etiological agents such as pathogens, genetic mutations, or environmental toxins leading to functional derangements like impaired metabolism, structural damage, or aberrant signaling. This initiation phase involves molecular and cellular responses, including , protein misfolding, or enzymatic dysregulation, which exceed compensatory mechanisms and manifest as early signs of dysfunction. For instance, in hypoxic conditions, cellular ATP depletion triggers or , marking the threshold from physiological adaptation to pathological onset. In infectious diseases, mechanisms of onset follow discrete stages: initial exposure via portals like respiratory or gastrointestinal tracts, followed by of pathogens to host receptors using adhesins, invasion through or toxin-mediated disruption of barriers, and infection establishment by evasion of innate immunity such as . Viral pathogens, for example, propagate onset by hijacking host machinery for replication, inducing cytopathic effects like membrane fusion or within hours to days post-exposure. Non-infectious onsets, such as in autoimmune conditions, arise from loss of self-tolerance, where or epigenetic changes trigger autoreactive T-cell activation against host tissues. Propagation refers to the amplification and dissemination of the initial insult, often through cascading inflammatory mediators, unchecked cellular proliferation, or systemic dissemination, transitioning local damage to widespread . Cytokine storms, as seen in severe infections, exemplify propagation by recruiting neutrophils and macrophages that release proteases and , exacerbating tissue injury beyond the primary site. In neoplastic diseases, propagation involves clonal expansion of mutated cells via promotion and evasion of , enabling through lymphatic or hematogenous routes. Chronic propagation in degenerative conditions, like neurodegeneration, occurs via prion-like templating where misfolded proteins induce conformational changes in neighboring molecules, propagating aggregates across neural networks. These mechanisms are modulated by host factors, including immune competence and genetic variability; for example, polymorphisms in genes can accelerate propagation in inflammatory diseases by amplifying signaling pathways. Resolution or persistence depends on whether repair mechanisms, such as or , restore balance or entrench chronicity, with unresolved propagation leading to organ failure in approximately 20-30% of severe cases across etiologies like or . Empirical models, derived from longitudinal cohort studies, confirm that early intervention targeting propagation nodes, such as JAK-STAT inhibitors for -driven spread, can halt progression in models of and viral encephalitides.

Disease Stages and Progression

The natural history of disease refers to the course of a pathological in an individual from inception through resolution or chronicity, absent therapeutic intervention. This progression unfolds through distinct phases influenced by interactions among etiological agents, host susceptibility, and environmental factors. Empirical observations, such as those in epidemiological studies, demonstrate that diseases typically advance from a pre-pathogenic stage—where exposure occurs without immediate harm—to , encompassing subclinical changes detectable only via biomarkers or imaging before overt symptoms emerge. In infectious diseases, which often follow a predictable temporal sequence, five primary stages characterize progression: the , during which the replicates asymptomatically (typically hours to weeks, varying by agent like 2-14 days for ); the prodromal stage with nonspecific or low-grade fever signaling immune activation; the acute illness phase marked by peak symptoms and load; the decline phase as immune clearance reduces severity; and , involving tissue repair and potential sequelae like post-viral fatigue documented in cohorts exceeding 10% of cases for certain respiratory viruses. These stages reflect causal mechanisms rooted in -host dynamics, with durations empirically derived from outbreak data; for instance, influenza incubation averages 2 days based on contact-tracing studies. Non-infectious diseases, including degenerative or neoplastic conditions, exhibit progression models emphasizing gradual accumulation of cellular damage or genetic alterations. Acute non-infectious disorders, such as , manifest rapid onset from precipitating events like plaque rupture, progressing to peak dysfunction within hours and resolving via or intervention, with mortality rates up to 10-15% in untreated cases per registry data. Chronic diseases, conversely, involve nonlinear worsening over years, often modeled via longitudinal biomarkers; for example, in , progression from to beta-cell failure spans 5-10 years on average, driven by hyperglycemia-induced , as quantified in cohort studies tracking HbA1c trajectories. These models, validated against patient-level data, distinguish empirical patterns from mechanistic simulations, revealing host factors like age or comorbidities accelerating decline by 20-50% in predictive analyses. Progression outcomes vary causally: resolution via immune or homeostatic mechanisms in self-limiting cases; chronicity from persistent triggers, as in autoimmune disorders where sustains tissue remodeling; or terminal decline culminating in organ failure or , with epidemiological spectra showing subclinical carriers (e.g., 20-30% in ) bridging stages without full manifestation. Factors modulating pace include agent —quantified by case-fatality ratios, such as 1-2% for seasonal —and host resilience, evidenced by genetic variants conferring resistance in 5-10% of populations for conditions like . Without intervention, unchecked propagation heightens complication risks, underscoring the deterministic role of unchecked pathophysiological cascades in empirical disease trajectories.

Complications and Multifactorial Interactions

Complications in disease encompass secondary medical conditions or adverse outcomes that arise as a direct or indirect consequence of the primary , often exacerbating morbidity or mortality. These may manifest as , secondary infections, or systemic failures, such as developing from influenza-induced respiratory compromise or deep vein thrombosis following prolonged immobility in hospitalized patients. In chronic conditions like diabetes mellitus, complications include microvascular damage leading to , neuropathy, and nephropathy, where sustained interacts with to impair tissue perfusion. Multifactorial interactions underlie many complications, wherein the primary disease engages with host vulnerabilities, concurrent comorbidities, and external modifiers to propagate adverse effects. Genetic predispositions, such as polymorphisms affecting or metabolic pathways, can amplify susceptibility; for example, variants in genes regulating may heighten the of cardiovascular events in patients with underlying or . Environmental factors, including tobacco exposure or poor nutrition, further interact synergistically, as seen in (COPD) where smoking-induced compounds age-related lung remodeling, precipitating acute exacerbations or cor pulmonale. Comorbidities exemplify these dynamics: and elevate complication rates in infectious illnesses by impairing immune clearance and promoting storms, as evidenced in heightened severe outcomes from respiratory pathogens. The interplay often follows a cascade model, where initial disease perturbations—such as ischemia in —trigger inflammatory cascades that, in interaction with modifiable risks like sedentary behavior, culminate in events like or . Nonmodifiable elements, including advanced age or , intersect with behavioral factors; for instance, in cancer, treatment-induced can interact with preexisting frailty to foster opportunistic infections, with incidence rates rising disproportionately in elderly cohorts due to and reduced T-cell diversity. Empirical data from cohort studies underscore that such interactions are dose-dependent: cumulative exposure to multiple risks correlates with exponential increases in complication probability, as in where synergizes with to accelerate progression. Diagnostic and prognostic challenges arise from these complexities, as isolated biomarkers may fail to capture interactive effects; integrated models incorporating polygenic risk scores with clinical variables better predict outcomes, revealing, for example, how gene-environment interactions modulate complication thresholds in multifactorial disorders like , where alleles interact with vascular risk factors to hasten neurodegeneration. Mitigation strategies emphasize addressing modifiable interactants early, though evidence indicates that interventions targeting single factors yield limited efficacy against entangled pathways, necessitating holistic approaches grounded in causal mapping of disease networks.

Diagnostic Approaches

Methods and Technologies

Diagnostic methods begin with patient history and , which provide initial clues to underlying through symptom reporting and observable signs such as , , and . Laboratory tests, including blood analyses for biomarkers like , electrolytes, and inflammatory markers, enable quantification of physiological derangements, with blood tests being among the most common for monitoring health and diagnosing conditions like or . Urine and stool analyses similarly detect metabolic, renal, or gastrointestinal abnormalities, while microbiological cultures identify pathogens in samples. Medical imaging technologies visualize internal structures non-invasively; X-rays, discovered in 1895, remain foundational for detecting fractures, pneumonias, and foreign bodies by differential absorption of radiation. Computed tomography (CT) scans, introduced in the 1970s, reconstruct cross-sectional images using rotating X-ray sources, offering superior detail for tumors, vascular issues, and trauma, though with higher radiation exposure. Magnetic resonance imaging (MRI) employs magnetic fields and radio waves to produce high-contrast soft tissue images without , excelling in neurological and musculoskeletal diagnostics since its clinical adoption in the 1980s. , utilizing high-frequency sound waves, provides real-time, portable imaging for obstetric, cardiac, and abdominal assessments, avoiding radiation entirely. Invasive procedures like biopsies extract tissue samples for histopathological analysis, confirming malignancies or inflammatory processes via microscopic examination, often guided by . Molecular diagnostics, including (PCR) developed in 1983, amplify DNA for detecting genetic mutations or pathogens with high sensitivity, as in . Next-generation sequencing (NGS) sequences entire genomes or targeted panels to identify hereditary diseases or somatic mutations in cancer, enabling precision diagnostics since its commercialization in the 2000s. Emerging technologies integrate (AI) for in imaging, improving detection accuracy for conditions like by analyzing datasets beyond human capability. Wearable sensors, such as smartwatches monitoring and , facilitate continuous data collection for early in cardiovascular or respiratory diseases, with AI algorithms processing signals for predictive alerts. Point-of-care devices, including biosensors for rapid assays, reduce diagnostic delays in resource-limited settings.

Limitations and Error Sources

Diagnostic approaches for diseases are inherently limited by the imperfect sensitivity and specificity of testing methods, which can lead to false negatives—failing to detect existing conditions—and false positives—incorrectly identifying disease in healthy individuals. Sensitivity measures the proportion of true positives among those with the disease, while specificity assesses true negatives among those without; tests with low sensitivity risk missing cases, as seen in early-stage cancers or infections where markers are absent, whereas low specificity contributes to unnecessary interventions, exemplified by PSA testing for prostate cancer yielding up to 75% false positives in some populations. These metrics vary by disease prevalence, with positive predictive value dropping in low-prevalence settings, amplifying error rates in screening programs. Cognitive errors in clinical reasoning represent a primary source of diagnostic inaccuracy, often stemming from biases such as anchoring on initial impressions or heuristics that prioritize recent or memorable cases over comprehensive . Studies attribute up to 75% of errors to flawed judgment, including premature closure of diagnostic hypotheses without exhaustive differential consideration, compounded by knowledge gaps or in high-volume settings. System-level failures exacerbate these, including breakdowns in test result communication—where 7-10% of results are not followed up promptly—and incomplete histories due to time constraints or poor documentation access, leading to missed critical data like prior exposures or genetic factors. Technological and methodological constraints further introduce errors, such as variability in laboratory assays from reagent inconsistencies or operator technique, yielding inter-lab discrepancies of 10-20% for certain biomarkers like troponin levels in cardiac diagnostics. Imaging modalities like CT or MRI suffer from interpretive subjectivity, with inter-observer variability rates of 10-30% for subtle lesions in conditions like early pneumonia or tumors, while algorithmic aids in AI-assisted diagnostics can propagate training data biases, overdiagnosing in underrepresented demographics. Evolving disease presentations, particularly in chronic or atypical cases, challenge static diagnostic criteria, often resulting in delayed recognition until advanced stages, as documented in vascular events or sepsis where initial symptoms mimic benign conditions. Measurement of errors themselves is confounded by retrospective bias and underreporting, with estimates suggesting diagnostic failures contribute to 10-15% of adverse events, though true incidence may be higher due to obscured consensus diagnoses.

Therapeutic Interventions

Pharmacological and Biological Treatments

Pharmacological treatments encompass the use of synthetic or semi-synthetic small-molecule drugs to target disease mechanisms, pathogens, or symptoms through chemical interactions with biological targets such as enzymes, receptors, or cellular pathways. Common categories include analgesics for pain relief, divided into non-narcotic options for mild cases and narcotics for severe pain; for bacterial infections; antivirals for viral diseases like ; and antihypertensives for cardiovascular conditions. These interventions have demonstrably extended , as evidenced by the post-1940s decline in infectious disease mortality following widespread antibiotic adoption, though efficacy varies by disease etiology and is limited by factors like , which affects over 1.27 million direct deaths annually as of 2019 estimates from data. Evidence for pharmacological efficacy often derives from randomized controlled trials (RCTs), which integrate pathophysiological mechanisms with clinical outcomes, yet these studies face biases such as incomplete blinding in non-placebo interventions and underrepresentation of diverse populations, potentially skewing results toward overestimation of benefits in select groups. For instance, in chronic disease management, adherence to regimens like statins for correlates with reduced cardiovascular events, but real-world effectiveness is tempered by non-compliance rates exceeding 50% in some cohorts. Research biases, including publication favoritism toward positive outcomes, further necessitate scrutiny, as negative trials are less likely to be reported, distorting meta-analyses. Biological treatments, or biologics, comprise large-molecule products derived from living organisms, such as proteins, antibodies, or cells, offering higher specificity by mimicking or enhancing endogenous processes compared to small-molecule drugs. Examples include insulin for management since its isolation in 1921, which restored metabolic control and prevented ketoacidosis-related deaths; monoclonal antibodies targeting cytokines like TNF-alpha in autoimmune diseases such as , achieving remission rates up to 40% in refractory cases; and interferons for viral infections and certain cancers. These therapies leverage the or replace deficient biologics, with efficacy supported by reduced inflammatory markers in conditions like via anti-IL12 agents. Despite advantages in precision, biological treatments carry risks of , leading to neutralizing antibodies in 5-30% of patients depending on the agent, and higher production costs limit . Real-world studies indicate variable effectiveness, such as in where biologics adjunct to DMARDs yield response rates of 20-60%, influenced by patient and disease duration, underscoring the need for personalized approaches amid research biases like selective reporting in industry-sponsored trials. Overall, both pharmacological and biological modalities succeed best when causally aligned with disease , as symptomatic relief alone fails to halt progression in multifactorial conditions.

Surgical and Procedural Options

Surgical interventions are indicated for diseases involving structural abnormalities, localized pathology, or functional impairments that cannot be adequately addressed through conservative or pharmacological means alone, such as acute infections requiring drainage, neoplasms demanding excision, or vascular occlusions necessitating revascularization. These procedures aim to cure, palliate, or prevent progression, with decisions guided by factors including disease stage, patient comorbidities, and potential for nonoperative resolution; for instance, emergency surgery is mandated in conditions like perforated viscera to avert peritonitis and sepsis. Evidence supporting specific indications varies, with some procedures like appendectomy for appendicitis backed by randomized trials showing reduced mortality compared to antibiotics alone, while others, such as certain elective resections, rely on observational data due to ethical barriers to withholding intervention. Approaches to encompass open techniques, which involve large incisions for direct visualization and manipulation of affected tissues, suitable for complex resections like in where margins must be precisely assessed. Minimally invasive methods, including and robotic-assisted , utilize small ports and endoscopic tools to minimize tissue trauma, yielding benefits such as shorter hospital stays (e.g., 1-2 days versus 5-7 for open in disease) and lower infection rates, though they may not suit all anatomies or emergencies. Endoscopic procedures, often categorized as interventional rather than fully surgical, enable , polypectomy, or stenting via natural orifices, as in for or . In cardiovascular diseases, procedural options like (angioplasty with stenting) restore luminal patency in , with over 1 million annual procedures in the U.S. demonstrating acute success rates exceeding 90% but requiring dual antiplatelet therapy to mitigate restenosis. Coronary bypass (CABG), a surgical staple for multivessel disease, improves long-term survival over medical management in diabetic patients with left main stenosis, per trials like the SYNTAX study. Orthopedic interventions address degenerative or inflammatory joint diseases through for meniscal tears in or total joint arthroplasty, with hip replacements lasting 15-20 years in 80-90% of cases and reducing pain while restoring mobility. Oncologic surgery remains foundational for localized solid tumors, involving en bloc resection to achieve negative margins, as in breast for early-stage , where local control rates approach 95% when combined with adjuvant radiation. Procedural alternatives to traditional include catheter-based therapies for , such as (TAVR) for severe in high-risk patients, which halves periprocedural mortality compared to open replacement in octogenarians. In gastrointestinal disorders, options like endoscopic mucosal resection target early neoplasms with curative intent and minimal morbidity. Utilization rates for these interventions exhibit geographic variability, potentially reflecting differences in or practice patterns rather than uniform evidence, underscoring the need for individualized risk-benefit assessment.

Rehabilitative and Palliative Measures

Rehabilitation encompasses a set of interventions designed to optimize individual functioning and reduce in persons affected by diseases, whether acute, chronic, or resulting from injuries. According to the , these measures address impairments across body functions, activities, and participation in society, applicable at any stage of illness to minimize disabling effects from conditions such as , cancer, and . , a core component, enhances recovery by improving strength, mobility, and ; for instance, early post-surgery reduces , , and perioperative complications. Occupational and speech therapies similarly target daily living skills and communication deficits, with indicating that higher therapy doses—ranging from 20 to 300 hours—yield significant motor and functional gains in conditions like . Multidisciplinary rehabilitation programs demonstrate associations with better functional exercise capacity, reduced dyspnea, and elevated in chronic disease patients, including those with respiratory or cardiovascular impairments. Disease-specific protocols, such as , lower mortality risks and improve function by mitigating modifiable risk factors through structured exercise and education. These interventions prevent functional deterioration even in severe cases, though access remains limited in low-resource settings due to infrastructural barriers. Palliative measures prioritize symptom management, psychological support, and quality-of-life enhancement without aiming for disease cure, distinguishing them from curative approaches that seek to eradicate underlying . In chronic illnesses like or , alleviates , , and , often concurrently with disease-modifying treatments, thereby decreasing unnecessary hospitalizations and healthcare utilization. Early integration improves physical symptom control, mood, and patient autonomy, particularly in settings where timely interventions enhance end-of-life experiences. , a subset focused on terminal phases, extends these principles by emphasizing comfort in home or facility-based environments, reducing burden through coordinated team-based care. Both rehabilitative and palliative strategies intersect in advanced disease management, where rehabilitation maintains residual function while palliation addresses unrelievable suffering; for example, in cancer or organ failure, combined approaches optimize outcomes beyond pharmacological limits. Empirical data underscore their non-curative yet causal roles in averting complications and supporting physiological resilience, though effectiveness hinges on individualized application and systemic integration rather than universal protocols.

Preventive Measures

Primary Prevention Strategies

Primary prevention encompasses interventions designed to avert the onset of disease by addressing risk factors before exposure or susceptibility leads to . This approach targets modifiable determinants such as environmental hazards, behavioral patterns, and biological vulnerabilities, relying on of causal links between exposures and disease incidence. For infectious diseases, stands as a cornerstone, stimulating immune responses to pathogens without causing illness. Global efforts since 1974 have averted 154 million deaths, predominantly among children under five, with vaccination alone preventing 94 million fatalities.00850-X/fulltext) and measures, including access to clean water and proper waste disposal, have historically reduced transmission of diarrheal diseases, typhoid, and helminth infections by interrupting fecal-oral pathways. In regions with improved sanitation infrastructure during the , infectious disease mortality declined sharply prior to widespread use, underscoring the causal role of hygiene in primary prevention. Chronic non-communicable diseases, which account for over 70% of global deaths, respond to modifications that mitigate risk factors like use, poor , inactivity, and excess alcohol. Adherence to healthy behaviors—such as regular , maintaining normal body weight, nonsmoking, and moderate alcohol intake—can reduce the incidence of , , and cancer by up to 80% in some populations. For instance, combined factors have been linked to 80% lower risk in longitudinal cohorts. policies promoting these strategies, including taxes and for , amplify individual efforts by altering environmental incentives. Environmental controls, such as vector management for or asbestos regulation for , exemplify targeted primary prevention by eliminating proximal causes. While effective, these strategies demand rigorous evaluation to distinguish from causation, as observational data can overestimate benefits without randomized or mechanistic understanding.

Secondary and Tertiary Prevention

Secondary prevention involves the early detection of disease in or presymptomatic individuals through systematic screening and diagnostic measures, followed by timely intervention to prevent or attenuate disease progression and complications. This approach targets at-risk populations to identify preclinical pathology, such as via mammographic screening for or fecal immunochemical testing for , allowing for interventions like surgical excision or lifestyle modifications that can avert advanced stages. For instance, randomized trials and modeling indicate that achieving universal colorectal cancer screening adherence could avert approximately 35,530 deaths annually in the United States by detecting and removing precancerous polyps. However, effectiveness varies by program implementation; tailored remote interventions have demonstrated increases in rates among rural women, potentially reducing mortality through earlier treatment. Tertiary prevention focuses on managing established diseases to minimize , restore function, and prevent further deterioration or secondary conditions, often through rehabilitative programs, chronic disease self-management, and supportive therapies. Examples include following , which reduces recurrent events by 20-30% via supervised exercise and risk factor control, and structured protocols that lower risks of and nephropathy through glycemic monitoring and pharmacological adherence. management models, such as multidisciplinary interventions addressing fear-avoidance behaviors, aim to curtail long-term impacts like reduced mobility or psychological . Outcomes from initiatives show that integrated tertiary strategies, including socioeconomic support and ongoing monitoring, enhance metrics, with evidence from global chronic disease programs indicating sustained reductions in hospitalization rates for conditions like .

Individual Agency and Public Policy

Individuals exercise agency in disease prevention primarily through voluntary adoption of health-promoting behaviors, including avoidance, regular , and nutritious dietary patterns, which links to substantial reductions in chronic disease incidence. For instance, cigarette smoking accounts for over 480,000 annual deaths in the United States, encompassing conditions like , , and , underscoring the preventive impact of abstinence. Meta-analyses confirm that lowers risk in a dose-response manner, with even modest increases conferring benefits such as reduced and improved metabolic function among both healthy and at-risk populations. Similarly, adherence to multiple healthy factors—such as nonsmoking, , and moderate alcohol consumption—correlates with extended disease-free , potentially adding over a without major chronic conditions like or heart disease. These choices operate via causal mechanisms rooted in , where reduced exposure to carcinogens, enhanced insulin sensitivity, and lower directly mitigate disease pathways, independent of socioeconomic confounders in observational and interventional studies. Public policies influence individual agency by shaping incentives and constraints, often through regulatory, fiscal, or informational interventions designed to amplify population-level prevention. measures, including excise taxes and indoor bans implemented since the , have demonstrably decreased U.S. prevalence from 42% in 1965 to about 12% by 2020, averting millions of attributable deaths via reduced initiation and increased cessation. Nutrition labeling requirements and restrictions exemplify policies that facilitate informed choices, correlating with shifts toward lower consumption of high-risk foods and subsequent declines in obesity-related comorbidities in jurisdictions with early adoption. programs, blending voluntary uptake with school-entry mandates, have eradicated or controlled infectious diseases like and globally, though their success hinges on high coverage thresholds for , achieved variably across populations. Evidence from systematic reviews indicates these policies yield net health gains, yet their design must account for , as nudges like graphic warnings prove more effective than outright prohibitions in sustaining long-term compliance without fostering resentment. Tensions arise when policies prioritize collective outcomes over personal , particularly with mandates that compel behavior under threat of penalty, as observed in debates over enforcement or requirements during infectious outbreaks. While proponents cite utilitarian benefits—such as averting in vulnerable groups—critics highlight overreach, noting historical precedents like smallpox rulings where courts upheld compulsion only under narrow public necessity, balanced against rights. First-principles evaluation reveals that coercive measures can erode trust and provoke backlash, potentially undermining voluntary adherence more than they achieve compliance, whereas and subsidy-based approaches preserve agency while harnessing social norms for prevention, as evidenced by sustained declines in following awareness campaigns rather than bans alone. Optimal thus integrates empirical effectiveness with respect for causal agency, favoring scalable, low-coercion tools that empower individuals to internalize behaviors, thereby minimizing unintended socioeconomic distortions like black markets or evasion.

Epidemiological Patterns

Incidence, Prevalence, and Determinants

Incidence quantifies the frequency of new disease cases arising in a over a defined period, typically reported as the number of incident cases per 1,000 or 100,000 person-years at risk, enabling assessment of disease emergence dynamics. measures the proportion of a affected by a disease at a specific point (point prevalence) or over an interval (period prevalence), expressed as cases per total , and is influenced by disease duration and incidence rates. For acute infectious diseases, such as seasonal , incidence peaks episodically, while prevalence remains lower due to resolution; in contrast, chronic conditions like exhibit sustained high prevalence from cumulative incidence and prolonged survival. Globally, the for 2023 estimates that non-communicable diseases (NCDs), including cardiovascular disorders and neoplasms, dominate and contribute over 70% of total disability-adjusted life years (DALYs), with approximately 41 million NCD-related deaths annually as of recent WHO data. Communicable, maternal, neonatal, and nutritional diseases saw DALY rates decline by nearly 26% from 2010 to 2023, reflecting effective interventions like , though absolute incidence persists in low-resource settings. Cancer incidence reached about 20 million new cases in 2022, with , , and colorectal types most common, underscoring rising trends in aging populations. These patterns highlight shifts from infectious to lifestyle-associated pathologies, with metrics often underestimating underdiagnosed conditions in underserved regions. Determinants of disease incidence and encompass agent-host-environment interactions, where causative agents (e.g., pathogens, toxins, or genetic mutations) encounter susceptible hosts amid facilitating conditions. Host factors include immutable traits like age, , and genetic vulnerabilities—evident in higher incidence of in postmenopausal women due to decline—and acquired states such as , which amplify opportunistic infections. Agent properties, including and , dictate transmission potential; for instance, variants with enhanced binding increased incidence during peaks. Environmental determinants involve physical elements (e.g., climate influencing vector-borne diseases like , with warmer temperatures expanding mosquito ranges) and socioeconomic conditions (e.g., elevating respiratory rates). Behavioral factors, often modifiable, exert causal influence on NCD incidence: use accounts for 8 million deaths yearly, primarily via and COPD, while sedentary behavior and caloric excess drive prevalence, now exceeding 1 billion adults globally as of 2022 estimates. These align with epidemiological models emphasizing dose-response relationships, such as linear increases in cardiovascular risk from untreated due to dietary sodium intake. Social determinants, including and , correlate with outcomes but operate through behavioral and access pathways, as lower links to higher prevalence via choice patterns rather than inevitability. Empirical data from cohort studies confirm that interventions targeting modifiable determinants, like , reduce incidence by 30-50% in exposed groups, underscoring causal priority over mere correlation.

Burden Assessment and Metrics

The burden of disease is quantified through metrics that integrate mortality, morbidity, and disability to evaluate population-level health impacts, enabling comparisons across conditions, regions, and time periods. The dominant metric, disability-adjusted life years (DALYs), measures the total years of healthy life lost, calculated as the sum of years of life lost (YLLs) due to premature death and years lived with disability (YLDs) from non-fatal health loss. YLLs are derived by multiplying deaths at each age by remaining standard life expectancy (typically 86 years at birth in GBD models), while YLDs multiply disease prevalence by disability weights ranging from 0 (no disability) to 1 (equivalent to death). These weights, informed by surveys of lay and expert perceptions, standardize severity but rely on subjective valuations that may undervalue conditions like chronic pain or mental disorders relative to acute physical impairments. The Global Burden of Disease (GBD) study by the Institute for Health Metrics and Evaluation (IHME) applies DALYs to estimate health loss from 371 diseases, injuries, and 88 risk factors annually since 1990, using statistical modeling to fill data gaps from vital registration, surveys, and claims databases. In 2021, global DALYs totaled 2.88 billion, up from 2.63 billion in 2010, driven primarily by , aging demographics, and shifts toward non-communicable diseases (NCDs) like cardiovascular conditions and neoplasms, which accounted for over 70% of the total. Complementary metrics include healthy life expectancy (HALE), which subtracts YLDs from , and attributable fractions linking DALYs to modifiable risks such as or poor diet. Economic extensions of burden assessment, such as cost-of-illness analyses, incorporate (e.g., treatment expenditures) and (e.g., lost ), though these lack the uniformity of DALYs and vary by ; for instance, NCDs imposed an estimated $1 trillion in annual global losses as of recent analyses. GBD estimates, while empirically grounded in vast datasets, depend on Bayesian and age-standardization assumptions that can introduce uncertainties, particularly in low-data regions, and have been critiqued for over-relying on modeled extrapolations that may align poorly with local causal realities or underemphasize infectious disease persistence in favor of NCD trends. Despite limitations, DALYs facilitate evidence-based , revealing, for example, that mental disorders contribute disproportionately to YLDs (over 20% globally in 2021) despite lower mortality shares.

Geographic and Demographic Variations

Infectious diseases, such as and , impose a disproportionately high burden in tropical and low-income regions like , where environmental factors including poor , vector proliferation, and limited coverage contribute to elevated incidence rates; for instance, in 2021, communicable, maternal, neonatal, and nutritional disorders accounted for over 40% of disability-adjusted life years (DALYs) lost in the WHO African Region. In contrast, high-income regions such as and experience a predominance of non-communicable diseases (NCDs) like cardiovascular conditions and cancers, driven by aging populations, sedentary lifestyles, and dietary factors, with NCDs comprising approximately 80-90% of DALYs in these areas as of 2021. These patterns reflect causal influences including suitability for pathogens, enabling chronic disease risk factors, and infrastructure disparities, rather than uniform global disease dynamics. Demographic variations further modulate disease patterns, with age serving as a primary determinant: incidence of chronic conditions like and escalates sharply after age 65, doubling DALYs from these causes between 2000 and 2021 globally due to cumulative physiological wear and reduced regenerative capacity. Sex-based differences are evident in many disorders; for example, men exhibit higher age-adjusted incidence rates for across ethnic groups, attributable to historical disparities and occupational exposures, while women face elevated risks for autoimmune diseases linked to hormonal and genetic factors. Ethnic and racial ancestries influence susceptibility via genetic predispositions and socioeconomic mediators; Hispanics display the highest age- and sex-adjusted incidence among U.S. populations, followed by , potentially reflecting unmeasured genetic variants or environmental interactions, whereas Black individuals experience disproportionate and prevalence tied to both heritable traits and lifestyle factors. These demographic gradients underscore the interplay of , , and access to care, with data indicating that earlier onset often occurs in males for numerous conditions, challenging assumptions of uniform progression across groups.

Key Controversies

Boundaries of Disease Definition

The boundaries of disease definition remain a central philosophical and practical challenge in , distinguishing pathological states from normal biological variation, risk factors, or socially disvalued traits. Naturalist theories, such as Christopher Boorse's biostatistical account, define disease as a statistically subnormal functioning of a body part or process relative to species-typical contributions to survival and reproduction, emphasizing empirical, value-neutral criteria derived from rather than subjective judgments. This approach posits that diseases involve identifiable causal disruptions, like genetic mutations or infections, that impair evolved functions, as seen in conditions such as , where insulin production fails below the observed in 95% of healthy populations. In contrast, normativist perspectives incorporate evaluative elements, arguing that disease requires not only dysfunction but also harm relative to cultural or individual values, though this risks conflating medical pathology with mere undesirability. Jerome Wakefield's hybrid "harmful dysfunction" analysis refines naturalism by requiring both a of an internal mechanism to perform its evolutionarily selected function and resultant , providing a framework particularly for mental disorders where pure statistical norms might pathologize adaptive traits. For instance, following loss may deviate from baseline functioning but lacks inherent dysfunction if it resolves adaptively, whereas prolonged major depression involves neurochemical imbalances harming survival prospects. This delineation avoids overpathologizing transient states, as evidenced by the American Psychiatric Association's 2013 decision to retain bereavement exclusion criteria for depression to prevent medicalizing normal sadness. Empirical support for such boundaries draws from , where dysfunctions correlate with reduced fitness; twin studies show heritability rates for at 80%, indicating genetic causal failures beyond volition or culture. Contested cases highlight definitional ambiguities, such as , classified as a disease by the in 2013 due to its association with comorbidities like (affecting 42% of U.S. adults per CDC data from 2017-2018), yet critiqued as blurring into modifiable risk factors driven by caloric imbalance rather than intrinsic dysfunction. Similarly, the World Health Organization's 1948 framing of health as "complete physical, mental, and social well-being" has been faulted for implying disease in any shortfall, enabling expansions like labeling mild (affecting 46% of adults globally in 2010) as despite lacking acute causal impairment in many cases. These expansions risk , where pharmaceutical interests influence thresholds—e.g., lowering guidelines in 2013 expanded treatment-eligible populations by 13 million Americans—potentially prioritizing profit over biological realism, as evidenced by reanalyses showing minimal mortality benefits for low-risk users. Rigorous boundaries thus demand verifiable mechanisms, such as histopathological evidence in cancer (e.g., uncontrolled ), over probabilistic risks or value judgments, safeguarding against pseudoscientific classifications like historical "" for enslaved persons' flight.

Overdiagnosis and Medicalization Risks

occurs when medical screening or diagnostic expansion identifies conditions that would not progress to cause symptoms or harm during a patient's lifetime, leading to unnecessary interventions and associated risks. Empirical studies indicate that is prevalent in screening programs for conditions like , where (PSA) testing has resulted in an estimated 1.5 to 1.9 million overdiagnosed cases among U.S. men over three decades, exposing many to overtreatment without mortality benefits. In the , approximately 10,000 men are overdiagnosed annually with due to PSA screening, incurring potential side effects from biopsies, surgeries, or radiation without altering disease outcomes for indolent tumors. Such patterns arise from lowered diagnostic thresholds and intensified screening, which detect biologically insignificant lesions, as evidenced by rising incidences of low-grade tumors correlating with screening uptake rates. Medicalization extends this risk by reclassifying normal human variations or mild conditions as pathological entities requiring medical management, often driven by pharmaceutical interests and diagnostic guideline expansions. For instance, attention-deficit/hyperactivity disorder (ADHD) diagnoses have surged, with systematic reviews identifying convincing evidence of and overtreatment in children and adolescents, including cases where symptoms overlap with normal developmental behaviors or environmental factors rather than inherent neurological deficits. U.S. data show ADHD rising from 6.1% to over 10% in two decades, prompting concerns over diagnostic criteria applied too broadly without rigorous differentiation from situational stressors or . This process imposes psychological burdens from labeling, financial costs from stimulants and therapies, and physiological risks from side effects like growth suppression or cardiovascular issues in otherwise healthy individuals. Both phenomena amplify harms through cascading effects: overdiagnosis prompts invasive follow-ups, while medicalization fosters dependency on interventions for non-disease states, as seen in primary care where general practitioners report overtreatment across fields due to fear of missing rare harms. Economic analyses highlight billions in avoidable expenditures, alongside equity issues where vulnerable populations face disproportionate labeling and intervention risks without proportional benefits. Critiques attribute these trends partly to institutional incentives, including academic and media amplification of low-risk findings, underscoring the need for causal validation before broadening disease boundaries to prioritize clinically meaningful pathology over statistical artifacts.

Chronic Conditions and Causal Attribution

Chronic conditions, encompassing non-communicable diseases such as , , and chronic respiratory disorders, typically persist for months or years and arise from complex interactions among genetic, behavioral, and environmental factors. Causal attribution requires demonstrating that specific exposures precede and mechanistically contribute to disease onset, often evaluated through epidemiological frameworks like the , which assess strength of association, consistency across studies, temporality, and biological gradient. These criteria have supported robust links, such as between prolonged tobacco exposure and chronic obstructive pulmonary disease (COPD), where dose-response relationships show heavy smokers facing risks over 10-fold higher than non-smokers. Lifestyle factors provide clear examples of attributable causation in many chronic conditions. Physical inactivity causally elevates risks for and cardiovascular events, with 1.8 billion adults globally at heightened vulnerability due to insufficient activity as of June 2024, contributing to heart attacks, , and related morbidity. Similarly, poor diet and sedentary behavior drive and , modifiable risks that interventions targeting and exercise can mitigate, as demonstrated in trials reducing incidence by altering these behaviors. Adherence to multiple healthy practices—avoiding , maintaining normal weight, regular exercise, and balanced diet—extends years lived free of major chronic diseases like and heart disease by up to a in population studies. Controversies in causal attribution often center on the weight given to individual behaviors versus broader determinants. In obesity, a precursor to diabetes, hypertension, and over a dozen cancers, genetic heritability accounts for substantial BMI variation, yet the condition's prevalence has tripled since 1975, implicating environmental shifts like increased ultra-processed food intake over innate factors alone. Debates persist on whether personal overconsumption or systemic food environments bear primary responsibility, with some attributions favoring socioeconomic explanations that correlate with but do not fully causally explain behavioral patterns. For cancers, obesity's role involves proposed mechanisms like adipose-driven inflammation and insulin resistance, though paradoxical protections—such as reduced premenopausal breast cancer risk—complicate uniform attribution. These disputes influence policy, as overemphasizing non-modifiable causes may diminish focus on evidence-based behavioral interventions. Patient-level causal perceptions add further layers, with individuals often attributing chronic illness onset to stress, immunity changes, or lifestyle, influencing adherence and outcomes; for instance, heart disease patients commonly cite modifiable factors like diet alongside immutable ones like heredity. In polycausal scenarios, such as metabolic syndrome linking obesity to cardiovascular and renal disease, disentangling contributions demands rigorous adjustment for confounders, revealing that while shared risks like inactivity and poor nutrition predominate, isolated genetic effects are modest without enabling environments.

Inclusion of Mental and Social Phenomena

The classification of mental phenomena as diseases remains contentious, primarily due to the absence of verifiable pathological lesions analogous to those in physical ailments. argued in his 1961 work The Myth of Mental Illness that psychiatric diagnoses represent metaphors for deviations from social norms rather than bona fide diseases, lacking demonstrable biological abnormalities in bodily organs. This view posits that labeling behaviors like distress or nonconformity as "illnesses" shifts responsibility from ethical and social judgments to medical authority, potentially undermining individual agency. Critics of Szasz, including proponents of the , counter that evidence from twin studies indicates substantial heritability for conditions such as (up to 80%) and (around 70-90%), suggesting genetic and neurobiological underpinnings. has revealed structural differences, like enlarged ventricles in patients, yet these findings often correlate with symptoms rather than establishing causation, and no specific biomarkers exist for most diagnostic categories in the DSM-5. A 2018 review of over 107,000 studies found insufficient evidence of consistent biological pathology for "mental illnesses" as a class, reinforcing skepticism about their equivalence to somatic diseases. Proponents of including mental phenomena emphasize functional impairments in , , and that mirror disease criteria, such as deviation from species-typical norms causing harm. For instance, disruptions in systems like in or serotonin in major depression have been linked to symptoms via pharmacological responses, with antipsychotics reducing rates by 50-70% in controlled trials. However, causal attribution remains elusive; environmental stressors, trauma, and cultural expectations often precipitate or exacerbate these states, blurring lines between and adaptive responses. This has led to debates over whether mental "disorders" are diseases or reactions to adversity, with the attempting reconciliation but criticized for diluting empirical rigor. Institutional biases in , influenced by pharmaceutical interests, may inflate biological claims; for example, the expansion of diagnostic criteria in successive DSM editions has correlated with rising prescription rates without proportional advances in . The inclusion of social phenomena as diseases exemplifies , whereby non-medical issues like behavioral deviance or societal dysfunctions are reframed as treatable pathologies, often expanding professional jurisdictions. This process, accelerated since the mid-20th century, transforms problems such as poverty-induced absenteeism or relational conflicts into "disorders" amenable to intervention, as seen in the rising diagnosis of depression in amid economic pressures, where social factors accounted for much of the increase rather than intrinsic biology. Critics argue this erodes personal and communal responsibility; for instance, attention-deficit/hyperactivity disorder (ADHD) is sometimes portrayed as a medicalization of mismatches between and modern schooling demands, with pharmaceutical treatments addressing symptoms over root social causes like family structure or educational fit. Empirical data show that social interventions, such as improved community ties, yield comparable outcomes to drugs for mild cases, questioning the necessity of disease labeling. From a causal realist perspective, social phenomena fail core disease hallmarks: they lack identifiable physiological lesions and often resolve through non-medical means, such as policy reforms or behavioral adjustments, without invoking . Yet, advocates frame issues like or inequality as "public health crises" akin to epidemics, citing correlations with mortality (e.g., raising by 29% in meta-analyses), but these represent risk factors, not diseases themselves. This blurring risks , as evidenced by the American Medical Association's 2013 designation of as a disease despite debates over its status as voluntary versus , potentially diverting from preventive emphases. Academic and media sources promoting such inclusions often exhibit ideological tilts toward collectivist solutions, underemphasizing agency; rigorous scrutiny reveals that while social environments modulate health, conflating them with disease conflates correlation with causation and invites iatrogenic harms from over-reliance on medical frames.

Historical Development

Ancient and Pre-Scientific Views

In ancient , dating back to the third millennium BCE, diseases were predominantly attributed to supernatural agents such as gods, demons, ghosts, or offended spirits, with each affliction linked to a specific entity responsible for particular symptoms or body parts affected. Treatments involved incantations, s, and exorcisms to appease these forces, alongside rudimentary herbal remedies and surgical practices, though accountability for healers rested on rather than empirical outcomes. Some recognition of internal bodily processes existed, but supernatural causation remained primary, reflecting a where illness signaled cosmic imbalance or divine displeasure. Ancient Egyptian medicine, from around 3000 BCE, similarly emphasized supernatural etiology, viewing diseases as arising from evil spirits, angry deities, or blockages in bodily channels influenced by external forces like ingested food or parasites, though mummification practices yielded advanced anatomical knowledge. Mental illnesses were explained as combinations of physiological obstructions and spiritual incursions, treated through spells, amulets, and pharmacopeia derived from empirical observation, such as the (c. 1550 BCE) detailing over 700 remedies. Despite magical elements, Egyptians distinguished between natural ailments addressable by physicians and those requiring priestly intervention, marking an early bifurcation between empirical and ritualistic approaches. In biblical Hebrew traditions, as recorded in texts from the second millennium BCE onward, diseases often signified divine punishment for moral or covenantal transgressions, with God portrayed as both the inflictor and healer of afflictions like leprosy or plagues. Priests diagnosed conditions such as skin diseases through ritual inspection (Leviticus 13-14), emphasizing spiritual purification over physiological intervention, though preventive hygiene laws like quarantine foreshadowed later public health measures. This moral-causal framework persisted, linking communal epidemics to collective sin, as in the plagues of Egypt (Exodus 7-12). Greek thought, particularly through (c. 460-370 BCE), shifted toward naturalistic explanations with humoral theory, positing disease as imbalances in four bodily fluids—blood, phlegm, yellow bile, and black bile—caused by diet, environment, or lifestyle rather than solely divine intervention. In works like , rejected as godly punishment, arguing instead for cerebral imbalances treatable through regimen and purgatives, influencing subsequent Western medicine by prioritizing observation over superstition. This framework extended to ’s Ayurveda (c. 1500 BCE onward), where disease stemmed from imbalances (vata, pitta, kapha) due to improper diet, emotions, or seasonal factors, advocating holistic restoration via herbs, , and lifestyle. Similarly, ancient Chinese medicine (c. 2000 BCE) attributed illness to disruptions in qi vital energy and yin-yang harmony, triggered by external pathogens like wind or cold, or internal excesses from unchecked emotions, treated through and herbal balancing without primary reliance on supernatural entities. Pre-scientific European views through the (c. 500-1500 CE) largely retained humoralism via (129-216 CE), who expanded it to include miasmatic "bad air" as a , alongside to restore fluid equilibrium. Epidemics like the (1347-1351 CE), killing 30-60% of Europe's population, were often interpreted as for sin, prompting processions and pogroms, though some physicians advocated and based on observed contagion patterns. This era blended empirical —evident in trephination for skull fractures—with astrological and theological causal attributions, delaying germ theory until the 19th century.

Scientific Revolution and Modern Paradigm Shifts

The marked a departure from Galenic humoral theory, which attributed disease to imbalances in bodily fluids, toward empirical observation and mechanistic explanations grounded in and . Andreas Vesalius's De humani corporis fabrica (1543) introduced detailed dissections that corrected ancient errors, establishing as a foundation for understanding pathological processes rather than relying on speculative . William Harvey's De Motu Cordis (1628) demonstrated blood circulation through quantitative experiments, undermining Galen's cardiac model and emphasizing causal flows in bodily systems over qualitative humors. These advances, driven by philosophical commitments to experimentation, shifted disease concepts from holistic imbalances to localized structural disruptions. In the , further shifts solidified a contagion-based , replacing —rooted in Galen's environmental vapors—with germ theory. Rudolf Virchow's cellular () posited disease as cellular abnormalities, providing a microscopic basis for lesions previously viewed macroscopically. Louis Pasteur's experiments (1860s) disproved and linked specific microbes to and , while Robert Koch's postulates (1890) formalized criteria for microbial causation, enabling targeted interventions like antisepsis. This causal realism reduced mortality from infectious diseases, as evidenced by declining rates post-vaccination and , though initial resistance from miasmatists highlighted institutional inertia. The 20th century extended these foundations into molecular paradigms, identifying viruses (e.g., , 1892) and developing antibiotics (penicillin, 1928), which halved infectious disease deaths by mid-century. Post-1950s, reframed etiology: Watson and Crick's DNA structure (1953) enabled insights into hereditary diseases, evolving to genomic sequencing that reveals variants in conditions like via single-gene defects. Modern shifts incorporate multi-omics, integrating and to explain chronic diseases' multifactorial causes—e.g., lifestyle-genome interactions in —beyond monocausal pathogens, though overemphasis on risks underplaying evident in twin studies. This progression prioritizes verifiable mechanisms, yet gaps persist in non-communicable etiologies, underscoring ongoing empirical refinement.

Broader Implications

Economic and Resource Burdens

Diseases impose substantial direct economic costs through medical treatments, hospitalizations, and pharmaceuticals, with global health expenditures averaging 7.09% of GDP across 186 countries in 2021. In high-income nations like the , this figure reached 17.6% of GDP as of 2023, driven primarily by disease-related care. Chronic conditions, which encompass cardiovascular diseases, cancers, , and respiratory illnesses, account for 90% of the ' $4.9 trillion in annual healthcare spending as of 2025. Projections indicate escalating burdens, with the worldwide cost of chronic diseases forecasted to accumulate $47 trillion by 2030, reflecting cumulative direct and indirect impacts from rising prevalence and aging populations. Non-communicable diseases alone contribute disproportionately, as evidenced by their role in 71% of global deaths and associated healthcare resource demands. Indirect costs amplify the economic toll via lost productivity, disability, and informal caregiving. For instance, Alzheimer's disease and other dementias generate annual indirect costs of $832 billion in the United States, including $599 billion in unpaid family caregiving and $233 billion in workforce productivity losses. Across diseases, such losses—measured through absenteeism, presenteeism, and premature mortality—often rival or exceed direct medical expenses, particularly for conditions affecting working-age populations like cardiovascular events or cancers. Resource burdens manifest in strained healthcare , where chronic diseases consume 86% of healthcare expenditures while affecting 50% of the , leading to overburdened facilities, personnel shortages, and inefficiencies in diversion. Rising chronic disease exacerbates this, with projections of increased disability-adjusted life years (DALYs) shifting toward years lived with (YLDs), from 41.1% globally in 2022 onward, necessitating reallocations of beds, staff, and diagnostics amid finite public and private resources. In low-resource settings, this strain manifests as delayed interventions and higher mortality from treatable conditions.

Cultural and Ethical Dimensions

Cultural conceptions of disease profoundly shape societal responses, integrating biological realities with interpretations rooted in cosmology, , and historical experience. In many non-Western societies, illness causation is ascribed to forces, such as ancestral spirits or , prompting rituals or consultations with traditional healers rather than biomedical interventions; for example, a 2017 study in rural identified socio-cultural beliefs in divine punishment as primary ill-health explanations, delaying clinic visits. Collectivistic cultures, prevalent in and parts of , frame health as a communal , fostering family-based caregiving and stigma avoidance through collective , while individualistic Western societies emphasize personal agency and disclosure for support networks. These variances persist despite , as evidenced by consistent cross-cultural beliefs in sensory cues for detecting , like visible or odor, which underpin avoidance behaviors from ancient to modern contexts. Stigma attached to diseases, especially infectious ones, amplifies cultural divides by associating affliction with moral failing or impurity, often overriding empirical transmission mechanisms. Historical precedents include biblical mandates for isolating patients based on skin lesions, institutionalizing exclusion that persisted into the with leprosaria worldwide. , rampant in from the , incurred shame linking it to , mirroring 1980s HIV/AIDS responses where U.S. cases surged from 41 in 1979 to over 100,000 by 1990 amid and intravenous drug users, hindering testing and care uptake. outbreaks, killing 25 million in during the 1347-1351 , fueled xenophobic of and outsiders, a pattern echoed in modern pandemics where spreads faster than pathogens, as seen in 2022 monkeypox attributions to specific demographics. Such stigma, while culturally adaptive for survival in pre-scientific eras by enforcing , now maladaptively impedes and , as with resurgences tied to historical fears rather than evidence. Ethically, disease management grapples with defining amid cultural overlays, where social norms risk pathologizing adaptive traits or vice versa, as in debates over expanding criteria for conditions like since the 1970s, potentially medicalizing normality without proportional benefits. Core principles—autonomy in , beneficence in promoting welfare, non-maleficence against harm, and in fair distribution—guide interventions, yet tensions arise in cross-cultural settings where patient refusals of blood products, rooted in beliefs like Jehovah's Witnesses' doctrines since 1945, challenge utilitarian outcomes. Resource scarcity, acute in pandemics like with over 7 million global deaths by 2023, demands allocation frameworks prioritizing prognosis, duration of benefit, and societal role over egalitarian lotteries; for instance, triage protocols from 2020 emphasized saving most lives over first-come-first-served to avert broader collapse. Medical anthropology's underscores respecting diverse illness narratives to build trust, but ethical imperatives subordinate unverified etiologies—such as —to causal evidence from pathogens or , ensuring interventions target verifiable mechanisms over ritual alone.

References

  1. https://pubmed.ncbi.nlm.nih.gov/756356/
  2. https://pubmed.ncbi.nlm.nih.gov/7393019/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC2465528/
  4. https://www.who.int/standards/classifications/classification-of-diseases
  5. https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-021-01501-1
  6. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/disease
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7150046/
  8. https://health.clevelandclinic.org/illness-vs-disease
  9. https://quizlet.com/in/329493228/core-aspects-of-diseases-in-pathology-flash-cards/
  10. https://basicmedicalkey.com/classification-and-incidence-of-disease/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC1299105/
  12. https://esmed.org/evolving-definitions-of-disease-implications-for-health-care/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC7120775/
  14. https://www.healthknowledge.org.uk/public-health-textbook/medical-sociology-policy-economics/4a-concepts-health-illness/section2
  15. https://sadarpsych.com/illness-vs-disease/
  16. https://www.lecturio.com/blog/syndrome-vs-disease-whats-the-difference/
  17. https://www.verywellhealth.com/disease-vs-syndrome-the-difference-715716
  18. https://share.upmc.com/2025/04/disease-disorder-syndrome/
  19. https://www.verywellhealth.com/disease-vs-disorder-5092243
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC1480257/
  21. https://www.ncbi.nlm.nih.gov/books/NBK224968/
  22. https://www.quora.com/What-is-the-difference-between-a-disease-disorder-disability-injury-and-illness
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC6327539/
  24. https://www.britannica.com/science/etiology
  25. https://study.com/learn/lesson/etiology-disease-categories-examples.html
  26. https://my.clevelandclinic.org/health/diseases/17724-infectious-diseases
  27. https://oncodaily.com/oncolibrary/etiology
  28. https://pubmed.ncbi.nlm.nih.gov/3205207/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC7768156/
  30. https://www.cdc.gov/nchs/data/misc/classification_diseases2011.pdf
  31. https://www.who.int/standards/classifications/international-classification-of-functioning-disability-and-health
  32. https://www.droracle.ai/articles/125453/acute-sub-acute-vs-chronic-
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC6082462/
  34. https://www.cdc.gov/pcd/issues/2013/12_0239.htm
  35. https://journals.sagepub.com/doi/full/10.1177/0192623318761348
  36. https://journals.lww.com/ajg/fulltext/2024/10001/s1207_identification_of_moderate_disease_severity.1208.aspx
  37. https://www.ncbi.nlm.nih.gov/books/NBK138596/
  38. https://reverehealth.com/live-better/systemic-diseases-versus-localized-diseases/
  39. https://www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/types-of-scleroderma
  40. https://www.ncbi.nlm.nih.gov/books/NBK26917/
  41. https://www.ncbi.nlm.nih.gov/books/NBK8526/
  42. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28OpenStax%29/15%253A_Microbial_Mechanisms_of_Pathogenicity/15.02%253A_How_Pathogens_Cause_Disease
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC7513766/
  44. https://www.mayoclinic.org/diseases-conditions/infectious-diseases/symptoms-causes/syc-20351173
  45. https://www.ncbi.nlm.nih.gov/books/NBK209710/
  46. https://www.cdc.gov/prions/about/index.html
  47. https://www.cdc.gov/mad-cow/php/animal-health/index.html
  48. https://www.atrainceu.com/content/4-element-ii-mechanisms-transmission
  49. https://my.clevelandclinic.org/health/body/23095-genetic-mutations-in-humans
  50. https://www.ncbi.nlm.nih.gov/books/NBK115561/
  51. https://guides.orchidhealth.com/post/monogenic-vs-polygenic-diseases
  52. https://medlineplus.gov/genetics/understanding/inheritance/inheritancepatterns/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC8317496/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC4919929/
  55. https://www.ncbi.nlm.nih.gov/books/NBK132134/
  56. https://www.mayoclinic.org/diseases-conditions/turner-syndrome/symptoms-causes/syc-20360782
  57. https://portlandpress.com/essaysbiochem/article/62/5/643/78430/The-genetic-basis-of-disease
  58. https://www.atsdr.cdc.gov/environmental-medicine/hcp/csemtakinganexposurehistory/index.html
  59. https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet
  60. https://www.stateofglobalair.org/hap
  61. https://www.who.int/data/gho/data/themes/air-pollution
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC4427717/
  63. https://rarediseases.org/rare-diseases/heavy-metal-poisoning/
  64. https://www.cdc.gov/united-states-cancer-statistics/publications/mesothelioma.html
  65. https://www.sciencedirect.com/science/article/abs/pii/S0041008X23002624
  66. https://beyondpesticides.org/dailynewsblog/2023/05/new-viewpoint-of-the-historic-link-between-endocrine-disrupting-chemicals-and-cancer-discussed/
  67. https://www.epa.gov/radon/health-risk-radon
  68. https://www.cancer.org/cancer/risk-prevention/radiation-exposure.html
  69. https://www.epa.gov/report-environment/connection-between-environmental-exposure-and-health-outcomes
  70. https://ehjournal.biomedcentral.com/articles/10.1186/s12940-022-00917-0
  71. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  72. https://www.ncbi.nlm.nih.gov/books/NBK43744/
  73. https://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html
  74. https://www.who.int/news-room/fact-sheets/detail/tobacco
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC11843939/
  76. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  77. https://www.who.int/news/item/26-06-2024-nearly-1.8-billion-adults-at-risk-of-disease-from-not-doing-enough-physical-activity
  78. https://www.cdc.gov/alcohol/facts-stats/index.html
  79. https://www.who.int/news-room/fact-sheets/detail/alcohol
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC10487788/
  81. https://www.cdc.gov/chronic-disease/about/index.html
  82. https://www.ncbi.nlm.nih.gov/books/NBK57011/
  83. https://www.primescholars.com/articles/understanding-pathophysiology-the-key-to-disease-mechanisms-132153.html
  84. https://www.jmolpat.com/jmolpat-articles/pathophysiology-understanding-the-causes-of-disease-processes-100769.html
  85. https://bio.libretexts.org/Courses/City_College_of_San_Francisco/Introduction_to_Microbiology_%28Liu_et_al.%29/17%253A_Pathogenicity_and_Virulence_Factors/17.01%253A_Stages_of_Pathogenesis
  86. https://www.ncbi.nlm.nih.gov/books/NBK8149/
  87. https://pmc.ncbi.nlm.nih.gov/articles/PMC10171171/
  88. https://www.nejm.org/browse/nejm-article-type/mechanisms-of-disease
  89. https://www.interesjournals.org/articles/pathogenesis-understanding-the-mechanisms-behind-disease-development-101036.html
  90. https://pmc.ncbi.nlm.nih.gov/articles/PMC7278211/
  91. https://www.annualreviews.org/content/journals/pathmechdis/browse
  92. https://www.sciencedirect.com/topics/medicine-and-dentistry/pathogenesis
  93. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson1/section9.html
  94. https://www.medicalnewstoday.com/articles/5-stages-of-infection
  95. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28Boundless%29/10%253A_Epidemiology/10.03%253A_Disease_Patterns/10.3B%253A_Disease_Development
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC5602534/
  97. https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%2522Disease%2BProgression%2522%255BMeSH%2BTerms%255D
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC9000925/
  99. https://www.rxlist.com/complication/definition.htm
  100. https://nowpatient.com/blog/most-common-diseases-and-health-risk-factors
  101. https://medlineplus.gov/genetics/understanding/mutationsanddisorders/complexdisorders/
  102. https://toolbox.eupati.eu/resources/risk-factors-in-health-and-disease/
  103. https://www.cdc.gov/covid/risk-factors/index.html
  104. https://www.uspharmacist.com/article/risk-factors-and-complications
  105. https://my.clevelandclinic.org/health/articles/complications
  106. https://www.creative-biolabs.com/gene-therapy/overview-of-multifactorial-disorders.htm
  107. https://pubmed.ncbi.nlm.nih.gov/12691175/
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC6038842/
  109. https://www.ncbi.nlm.nih.gov/books/NBK338590/
  110. https://my.clevelandclinic.org/health/diagnostics/24508-blood-tests
  111. https://medlineplus.gov/lab-tests/
  112. https://www.fda.gov/radiation-emitting-products/radiation-emitting-products-and-procedures/medical-imaging
  113. https://blog.radiology.virginia.edu/different-imaging-tests-explained/
  114. https://www.houstonphysicianshospital.com/the-5-most-common-medical-imaging-techniques/
  115. https://www.nps.org.au/consumers/imaging-explained
  116. https://www.ncbi.nlm.nih.gov/books/NBK593686/
  117. https://www.ncbi.nlm.nih.gov/books/NBK560712/
  118. https://www.nationaljewish.org/for-professionals/diagnostic-testing/advanced-diagnostic-laboratories/our-laboratories/molecular-genomics/molecular-diagnostic-technology
  119. https://bmcmethods.biomedcentral.com/articles/10.1186/s44330-024-00010-7
  120. https://pmc.ncbi.nlm.nih.gov/articles/PMC10708748/
  121. https://www.longdom.org/open-access/diagnostic-tools-an-overview-of-key-technologies-in-modern-healthcare-1100599.html
  122. https://www.ncbi.nlm.nih.gov/books/NBK557491/
  123. https://www.health.ny.gov/diseases/chronic/discreen.htm
  124. https://journals.sagepub.com/doi/full/10.1177/03000605231162798
  125. https://www.ahrq.gov/downloads/pub/advances/vol2/schiff.pdf
  126. https://qualitysafety.bmj.com/content/33/10/642
  127. https://www.ncbi.nlm.nih.gov/books/NBK338594/
  128. https://pmc.ncbi.nlm.nih.gov/articles/PMC4779119/
  129. https://news.harvard.edu/gazette/story/2024/01/research-assesses-rates-causes-of-diagnostic-errors/
  130. https://www.fda.gov/drugs/investigational-new-drug-ind-application/general-drug-categories
  131. https://pmc.ncbi.nlm.nih.gov/articles/PMC3981088/
  132. https://pmc.ncbi.nlm.nih.gov/articles/PMC11580118/
  133. https://www.cdc.gov/mmwr/volumes/66/wr/mm6645a2.htm
  134. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15863
  135. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003894
  136. https://www.who.int/health-topics/biologicals
  137. https://pmc.ncbi.nlm.nih.gov/articles/PMC3616818/
  138. https://pmc.ncbi.nlm.nih.gov/articles/PMC1860592/
  139. https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-88
  140. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.927179/full
  141. https://www.nature.com/articles/s41467-024-45718-w
  142. https://pubmed.ncbi.nlm.nih.gov/9388089/
  143. https://www.sciencedirect.com/topics/medicine-and-dentistry/surgical-treatment
  144. https://musculoskeletalkey.com/general-concepts-indications-for-surgery/
  145. https://www.ncbi.nlm.nih.gov/books/NBK6880/
  146. https://www.ncbi.nlm.nih.gov/books/NBK588031/
  147. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/methods-of-surgery
  148. https://www.ncbi.nlm.nih.gov/books/NBK588053/
  149. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/common-surgical-procedures
  150. https://www.mayoclinic.org/tests-procedures/minimally-invasive-surgery/about/pac-20384771
  151. https://www.healthdirect.gov.au/health-topics/procedures
  152. https://www.who.int/news-room/fact-sheets/detail/rehabilitation
  153. https://pmc.ncbi.nlm.nih.gov/articles/PMC5506300/
  154. https://www.obrienphysicaltherapy.net/blog/post-stroke-rehabilitation-outcomes-statistics-on-physical-therapy-effectiveness
  155. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809670
  156. https://www.mdpi.com/2227-9032/11/20/2751
  157. https://www.sciencedirect.com/science/article/pii/S0953620518304126
  158. https://www.painscale.com/article/what-is-the-difference-between-curative-care-and-palliative-care
  159. https://www.who.int/news-room/fact-sheets/detail/palliative-care
  160. https://pmc.ncbi.nlm.nih.gov/articles/PMC11277722/
  161. https://contessahealth.com/palliative-care-and-its-role-in-chronic-conditions/
  162. https://pmc.ncbi.nlm.nih.gov/articles/PMC5135526/
  163. https://globalheartjournal.com/articles/10.5334/gh.1360
  164. https://www.iwh.on.ca/what-researchers-mean-by/primary-secondary-and-tertiary-prevention
  165. https://www.ncbi.nlm.nih.gov/books/NBK537222/
  166. https://www.who.int/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years
  167. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4829a1.htm
  168. https://www.sciencedirect.com/science/article/pii/S1438463917301529
  169. https://www.cdc.gov/chronic-disease/prevention/index.html
  170. https://pmc.ncbi.nlm.nih.gov/articles/PMC11604909/
  171. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763720
  172. https://www.ahajournals.org/doi/10.1161/circulationaha.108.781062
  173. https://www.kingsfund.org.uk/insight-and-analysis/long-reads/what-is-prevention-in-health
  174. https://phprimer.afmc.ca/en/part-i/chapter-4/
  175. https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-10-10
  176. https://www.cdc.gov/pcd/issues/2020/20_0039.htm
  177. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804253
  178. https://www.iasp-pain.org/resources/fact-sheets/secondary-and-tertiary-prevention-of-chronic-pain/
  179. https://www.cdc.gov/pcd/issues/2021/21_0055.htm
  180. https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2014.302041
  181. https://www.ncbi.nlm.nih.gov/books/NBK294316/
  182. https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004
  183. https://pubmed.ncbi.nlm.nih.gov/39381478/
  184. https://pmc.ncbi.nlm.nih.gov/articles/PMC10650398/
  185. https://www.ajpmonline.org/article/S0749-3797%2823%2900515-9/fulltext
  186. https://www.regiscollege.edu/blog/public-health/what-is-health-policy
  187. https://pmc.ncbi.nlm.nih.gov/articles/PMC11003486/
  188. https://www.sciencedirect.com/science/article/pii/S2542454823000577
  189. https://www.networkforphl.org/news-insights/individual-rights-and-the-publics-health-constitutional-ethical-and-political-aspects-of-covid-19-measures-and-their-enforcement/
  190. https://digitalcommons.fau.edu/cgi/viewcontent.cgi?article=1018&context=ulj
  191. https://pmc.ncbi.nlm.nih.gov/articles/PMC2267241/
  192. https://www.infectiousdiseaseadvisor.com/features/public-health-imperatives-vs-individual-freedoms/
  193. https://www.healthknowledge.org.uk/e-learning/epidemiology/practitioners/measures-disease-frequency-burden
  194. https://www.ncbi.nlm.nih.gov/books/NBK7993/
  195. https://www.thelancet.com/gbd
  196. https://www.who.int/data/gho/publications/world-health-statistics
  197. https://www.healthdata.org/news-events/newsroom/news-releases/new-global-burden-disease-study-mortality-declines-youth-deaths
  198. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21834
  199. https://ourworldindata.org/burden-of-disease
  200. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson1/section8.html
  201. https://pmc.ncbi.nlm.nih.gov/articles/PMC12082254/
  202. https://www.who.int/news-room/questions-and-answers/item/determinants-of-health
  203. https://www.cdc.gov/about/priorities/why-is-addressing-sdoh-important.html
  204. https://www.who.int/health-topics/social-determinants-of-health
  205. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson1/section1.html
  206. https://www.healthdata.org/research-analysis/about-gbd
  207. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys
  208. https://www.healthdata.org/research-analysis/gbd
  209. https://pmc.ncbi.nlm.nih.gov/articles/PMC8862017/
  210. https://www.healthdata.org/research-analysis/library/global-incidence-prevalence-years-lived-disability-ylds-disability
  211. https://ghdx.healthdata.org/record/ihme-data/gbd-2021-yld-daly-hale-1990-2021
  212. https://www.healthdata.org/research-analysis/gbd-data
  213. https://pmc.ncbi.nlm.nih.gov/articles/PMC7567026/
  214. https://academic.oup.com/phe/article/10/3/244/4082024
  215. https://ghdx.healthdata.org/record/ihme-data/gbd-2021-burden-by-risk-1990-2021
  216. https://pmc.ncbi.nlm.nih.gov/articles/PMC7152081/
  217. https://www.mdpi.com/2072-6694/16/5/989
  218. https://academic.oup.com/aje/article/157/11/1015/151509
  219. https://www.ncbi.nlm.nih.gov/books/NBK425844/
  220. https://www.nature.com/articles/s41467-019-08475-9
  221. https://plato.stanford.edu/entries/health-disease/
  222. https://bioetyka.uw.edu.pl/wp-content/uploads/2014/10/06_BoorseHealthConcept.pdf
  223. https://shs.hal.science/halshs-01499883
  224. https://psycnet.apa.org/record/1992-27354-001
  225. https://philpapers.org/rec/MURTHD
  226. https://direct.mit.edu/books/oa-edited-volume/5015/Defining-Mental-DisorderJerome-Wakefield-and-His
  227. https://pmc.ncbi.nlm.nih.gov/articles/PMC1733381/
  228. https://esmed.org/MRA/mra/article/view/3599
  229. https://dash.harvard.edu/bitstreams/7312037c-74c8-6bd4-e053-0100007fdf3b/download
  230. https://pmc.ncbi.nlm.nih.gov/articles/PMC9888582/
  231. https://www.who.int/about/governance/constitution
  232. https://jme.bmj.com/content/45/9/579
  233. https://philosmed.wordpress.com/2015/08/18/defining-the-boundaries-of-disease/
  234. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200031
  235. https://www.bmj.com/company/newsroom/prostate-cancer-test-by-request-policies-drive-overdiagnosis-and-inequity-with-minimal-benefit-argue-experts/
  236. https://pmc.ncbi.nlm.nih.gov/articles/PMC8042533/
  237. https://add.org/adhd-overdiagnosis/
  238. https://pmc.ncbi.nlm.nih.gov/articles/PMC6135119/
  239. https://pmc.ncbi.nlm.nih.gov/articles/PMC5689393/
  240. https://pubmed.ncbi.nlm.nih.gov/35937061/
  241. https://pmc.ncbi.nlm.nih.gov/articles/PMC3081443/
  242. https://www.ncbi.nlm.nih.gov/books/NBK585052/
  243. https://www.sciencedirect.com/science/article/pii/S2542454824000031
  244. https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet
  245. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-11065-4
  246. https://pmc.ncbi.nlm.nih.gov/articles/PMC8414651/
  247. https://pmc.ncbi.nlm.nih.gov/articles/PMC9985585/
  248. https://www.tandfonline.com/doi/abs/10.1080/08870440108405491
  249. https://www.cdc.gov/pcd/issues/2025/24_0539.htm
  250. https://depts.washington.edu/psychres/wordpress/wp-content/uploads/2017/07/100-Papers-in-Clinical-Psychiatry-Conceptual-issues-in-psychiatry-The-Myth-of-Mental-Illness.pdf
  251. https://www.psychiatrictimes.com/view/mental-illness-vs-brain-disorders-szasz-dsm-5
  252. https://www.apa.org/monitor/2012/06/roots
  253. https://pmc.ncbi.nlm.nih.gov/articles/PMC7216390/
  254. https://www.madinamerica.com/2018/01/mental-illnesses-arent-real-illnesses/
  255. https://direct.mit.edu/daed/article/152/4/186/118239/The-Biology-of-Mental-Disorders-Progress-at-Last
  256. https://www.psychologytoday.com/us/blog/psych-unseen/202301/are-mental-disorders-brain-diseases-or-trauma-reactions
  257. https://pmc.ncbi.nlm.nih.gov/articles/PMC4409431/
  258. https://www.sciencedirect.com/topics/social-sciences/medicalization
  259. https://onlinelibrary.wiley.com/doi/10.1111/ijjs.12105
  260. https://pmc.ncbi.nlm.nih.gov/articles/PMC6687270/
  261. https://uhfnyc.org/publications/publication/medicalizing-social-needs-is-a-band-aid-and-not-a-cure/
  262. https://link.springer.com/article/10.1007/s11229-023-04468-w
  263. https://link.springer.com/rwe/10.1007/978-94-024-2252-8_74
  264. https://med.nyu.edu/departments-institutes/population-health/divisions-sections-centers/medical-ethics/education/high-school-bioethics-project/learning-scenarios/medicalization-ethics
  265. https://journals.lww.com/jsci/fulltext/2019/46030/medicalization___a_growing_problem.2.aspx
  266. https://www.worldhistory.org/article/687/medicine-in-ancient-mesopotamia/
  267. https://www.ancient-origins.net/news-general/unravelling-mystery-disease-ancient-mesopotamia-001378
  268. https://researchoutreach.org/articles/investigating-healing-arts-ancient-mesopotamia/
  269. https://www.history.com/articles/ancient-egyptian-medicine-cancer-treatment
  270. https://www.interesjournals.org/articles/the-egyptian-theory-of-wxdw-and-the-ancient-greek-medicinex-84351.html
  271. https://www.medicalnewstoday.com/articles/323633
  272. https://pmc.ncbi.nlm.nih.gov/articles/PMC8459052/
  273. https://www.myjewishlearning.com/article/illness-healing/
  274. https://www.thetorah.com/article/is-illness-a-divine-punishment
  275. https://journalofethics.ama-assn.org/article/legacy-humoral-medicine/2002-07
  276. https://pdxscholar.library.pdx.edu/cgi/viewcontent.cgi?article=1095&context=younghistorians
  277. https://pmc.ncbi.nlm.nih.gov/articles/PMC3705899/
  278. https://health.howstuffworks.com/wellness/natural-medicine/chinese/traditional-chinese-medicine-causes-of-illness.htm
  279. https://www.worldscientific.com/doi/10.1142/9781800613089_0003
  280. https://pmc.ncbi.nlm.nih.gov/articles/PMC3573364/
  281. https://www.history.com/articles/black-death
  282. https://pmc.ncbi.nlm.nih.gov/articles/PMC4762440/
  283. https://www.britannica.com/science/history-of-medicine/The-spread-of-new-learning
  284. https://www.journals.uchicago.edu/doi/10.1086/658659
  285. https://naturespharmacy.substack.com/p/paradigm-shifts-in-the-history-of
  286. https://pmc.ncbi.nlm.nih.gov/articles/PMC9609744/
  287. https://www.researchgate.net/publication/51214026_The_History_of_Medicine_and_the_Scientific_Revolution
  288. https://www.nejm.org/doi/full/10.1056/NEJMp2030694
  289. https://pmc.ncbi.nlm.nih.gov/articles/PMC10853174/
  290. https://cjgh.org/articles/10.15566/cjgh.v2i1.37
  291. https://www.ncbi.nlm.nih.gov/books/NBK11740/
  292. https://www.theglobaleconomy.com/rankings/health_spending_as_percent_of_gdp/
  293. https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical
  294. https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html
  295. https://pmc.ncbi.nlm.nih.gov/articles/PMC10830426/
  296. https://pubmed.ncbi.nlm.nih.gov/39571734/
  297. https://link.springer.com/chapter/10.1007/978-1-59259-398-9_5
  298. https://pmc.ncbi.nlm.nih.gov/articles/PMC7077778/
  299. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext
  300. https://www.cdc.gov/pcd/issues/2024/23_0267.htm
  301. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4052-y
  302. https://kidsnewtocanada.ca/culture/How-Culture-Influences-Health
  303. https://www.sciencedirect.com/science/article/abs/pii/S0889159125001576
  304. https://journalofethics.ama-assn.org/article/stigmatization-complicates-infectious-disease-management/2010-03
  305. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2899%2990358-6/fulltext
  306. https://www.gideononline.com/blogs/infectious-diseases-history/
  307. https://stories.uq.edu.au/contact-magazine/2022/history-repeating-when-prejudice-spreads-faster-than-disease/index.html
  308. https://pmc.ncbi.nlm.nih.gov/articles/PMC4251586/
  309. https://www.ama-assn.org/about/ethics/how-diseases-get-defined-and-why-it-matters
  310. https://pmc.ncbi.nlm.nih.gov/articles/PMC7923912/
  311. https://www.nejm.org/doi/full/10.1056/NEJMsb2005114
  312. https://code-medical-ethics.ama-assn.org/ethics-opinions/allocating-limited-health-care-resources
  313. https://socialsci.libretexts.org/Bookshelves/Anthropology/Introductory_Anthropology/Introduction_to_Anthropology_%28OpenStax%29/17%253A_Medical_Anthropology/17.04%253A_Theories_and_Methods
  314. https://www.researchgate.net/publication/376813484_Influence_of_culture_on_disease_perception
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.